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ABSTRACT OF DISSERTATION

THE SKELETAL MUSCLE MOLECULAR CLOCK REGULATES THE TIMING OF
SUBSTRATE METABOLISM AND THE CIRCADIAN EXPRESSION OF TITIN-CAP
Skeletal muscle is a major contributor to whole-body metabolism as it serves
as a depot for both glucose and amino acids, and is a highly metabolically active
tissue. An intrinsic molecular clock mechanism exists within skeletal muscle that
regulates the timing of physiological processes. A key function of the clock is to
regulate the timing of metabolic processes to anticipate time of day changes in
environmental conditions. The purpose of this study was to identify metabolic genes
that are expressed in a circadian manner and determine if these genes are regulated
downstream of the intrinsic molecular clock by assaying gene expression in an
inducible skeletal muscle-specific Bmal1 knockout mouse model (iMS-Bmal1−/−).
The skeletal muscle circadian transcriptome we analyzed was highly enriched for
metabolic processes. Acrophase (time of peak expression) analysis of circadian
metabolic genes revealed a temporal separation of genes involved in substrate
utilization and storage over a 24-h period with many differentially expressed in the
skeletal muscle of the iMS-Bmal1−/− mice compared to wildtype. However, the iMSBmal1−/− mice displayed circadian behavioral rhythms indistinguishable from iMSBmal1+/+ mice. We also observed a gene signature indicative of a fast to slow fibertype shift and a more oxidative skeletal muscle in the iMS-Bmal1−/− model. These
data provide evidence that the intrinsic molecular clock in skeletal muscle
temporally regulates genes involved in the utilization and storage of substrates
independent of circadian activity. Disruption of this mechanism caused by phase
shifts (that is, social jetlag) or night eating may ultimately diminish skeletal muscle’s
ability to efficiently maintain metabolic homeostasis over a 24-h period.
The molecular-clock targets genes for circadian expression in a tissuespecific manner, possibly through interactions with tissue-specific factors. In order
to identify novel mechanisms responsible for driving circadian gene expression of

muscle-specific genes we focused our study on the molecular regulation of the Titincap gene. We choose this gene as it was highly circadian in the skeletal muscle
circadian transcriptome, and has previously been shown to be modulated by the
clock factor BMAL1 in heart-tissue, and the myogenic regulatory factor MYOD1 in
skeletal-muscle. Promoter-reporter experiments demonstrated that BMAL1:CLOCK
and MYOD1 work in a synergistic fashion to transactivate the Titin-cap gene in
skeletal-muscle. Circadian expression of Titin-cap relied on the normal function of
MYOD1 as mutant vectors altered the rhythmic oscillation and expression. We
provided evidence that BMAL1 and MYOD1 bind to a tandem E-Box element in the
proximal promoter element, and that this element is required for the circadian
expression of Titin-cap in skeletal-muscle. These data provide a novel mechanism in
which the molecular-clock works with a tissue specific transcription factor to drive
circadian gene expression.
KEYWORDS: Circadian; Molecular-clock; Skeletal muscle; Metabolism; Bmal1;
Myod1
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Chapter 1: Introduction
Throughout the history of life on Earth, organisms have experienced the diurnal
periodicity of light and dark caused by the axial rotation of the Earth around the
sun.[1-3] Pressures caused by daily oscillations in the environment have favored the
evolution of organisms that have adopted 24-hour rhythmic cycles, or circadian
rhythms.[4-6] The term ‘circadian’ stems from the Latin words ‘Circa’ and ‘diem’,
and can be roughly translated to “about a day”. Numerous circadian descriptors are
commonly used to define the patterns of these rhythms, and most common of which
include ‘phase’, ‘amplitude’, and ‘period’ (Figure 1).[7] The phase of the rhythm
denotes a particular time within the rhythm and is most often associated with the
peak or highest point of the rhythm. Classically, phase is often used to describe
‘circadian time’ (CT) where ‘CT 0’ denotes the beginning of the inactive period, while
‘CT 12’ denotes the beginning of the active period. The amplitude of the rhythm
describes the difference between the peak/trough of the rhythm and the calculated
mean value. Typically, the amplitude of the rhythm is most often interpreted as the
strength or robustness of the rhythm.[8-12] Lastly, the period of the rhythm
describes the length in time it takes to complete one full cycle.[9]

1.1 Circadian Rhythms and Health
Growing evidence supports the association between circadian rhythms and human
health.[13] Multiple physiological processes display robust circadian oscillations
throughout the day and include fluctuations in core-body temperature, metabolic
flux, hormone release, immune function, sleep-wake cycles, and athletic
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Period

Amplitude

Acrophase
Time

Figure 1. Representative diagram of the circadian descriptors from a
typical
Figurerhythm.
23. Representative graph of baseline subtracted T-cap:luciferase
reporter values with co-transfection of MYOD1 (A) and MYOD1-3Δ56 (B).
Error bars denoted SEM. Red circles indicate the co-transfected values. The
black circles represents T-cap:luciferase values with no co-transfection.
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performance.[14-19] Disruptions in circadian rhythms and/or mutations in the
genes that regulate the body’s circadian clock have been linked to sleep disorders,
obesity, diabetes, psychological disorders (e.g. sleep disorders and bipolar
disorder), and others.[20-25] Recent advances in circadian bioinformatics have led
to the identification of the circadian transcriptional landscape in a variety of
mammalian tissues. These studies have identified many circadian transcripts that
encode proteins that are known drug targets. These findings suggest that the
efficacy of many drugs may fluctuate throughout the day.[26-28] Surprisingly,
Hogenesch et al. reported that 56 of the 100 top-selling drugs target proteins
encoded by circadian genes.[27] Identifying ways to promote normal circadian
rhythms hold promise in treating disease and furthering human health.

1.2 Molecular-Clock Background
Circadian rhythms are generated by an intrinsic molecular clock mechanism that
has remained highly conserved throughout evolution, and is present in all most all
cellular life-forms on earth including unicellular protozoa, insects, vertebrates,
plants, and mammals.[29-35] These clocks serve to align behavior and physiological
processes with the rising and setting of the sun, and thus allow organisms to more
efficiently anticipate, and adapt to environmental changes (nutritional availability,
predation, etc.) that occur throughout the day.[36] A fundamental component of
circadian rhythms is the cell-autonomous nature in which they exist. In other
words, circadian rhythms are intrinsic, and do not require an external stimulus to
provoke a response, as is most often observed in physiological systems, but exist in
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robust fashion even in the absence of environmental stimuli.[1, 37, 38] The notion
that circadian rhythms are not a mere byproduct of exogenous time-cues was a
long-standing topic of debate in the field of chronobiology, originating from what
some claim to be the very first circadian study. In 1792 a French astronomer, JeanJacques d’Ortous de Mairan, found himself very interested in the heliotrope plant,
because of the daily opening and closing of its leaves.[39] With no general
knowledge of circadian rhythms, Mairan hypothesized that the leaves opened
everyday in response to sunlight. He then tested this idea by recording the leaf
activity when the plant was placed in constant darkness. To his surprise, the leaves
opened during the day then closed again at night in the absence of light cues.
Mairan was not convinced that all possible confounding environmental factors were
properly controlled for, and suggested that light-leak was the most likely scientific
explanation. Chronobiologists have since repeated this experiment with proper
controls, and put to rest the notion that circadian rhythms are a direct response of
exogenous time-cues, although light and other environmental cues help to entrain
circadian rhythms. The birth of modern molecular genetic approaches and the use
of forward-genetic screens have allowed investigators to identify the molecular
components responsible for keeping biological time and has transformed the field of
circadian rhythms.
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1.2.1 Molecular-Clock Mechanism
Circadian rhythms in behavioral and physiology are generated by what is commonly
referred to as the ‘molecular-clock’.[40] This machinery is genetically programmed
within the majority of cells in the body, and exist in a highly organized and
hierarchal manner.[41] The master-clock, located in the region of the brain known
as the suprachiasmatic nucleus (SCN), processes light information from the
retinohypothalamic tract to synchronize its internal clock to the light:dark cycle.[4244] The SCN serves to relay light information to the clocks in the peripheral tissues
via multiple entrainment pathways by temporally regulating hormone release, the
autonomic nervous system, core body temperature, and behavior (feeding,
activity).[45] In effect, the SCN synchronizes the peripheral clocks so they run in
concert, and loss of a functional SCN results in the di-synchrony of the peripheral
clocks.[46] The peripheral clocks can sense environmental and systemic cues and
adjust (i.e. phase-shift) their rhythms to temporally align with the environment.[47]
For instance, the clocks in skeletal muscle can be entrained by time of feeding
and/or exercise. Social jet-lag, or misaligning the body’s internal clock with social
time, has become increasingly common in our modern society and has been
associated with detrimental health effects.[48] The molecular-clock’s ability to
phase-shift provides additional flexibility to the system, and allows organisms to
quickly adjust to alterations in the timing of the external light-cycle (i.e. travel
across time zones).
The molecular-clock mechanism is composed of two interconnected transcriptionaltranslational feedback loops that generate molecular rhythms of gene expression
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with an approximate 24-hour periodicity.[49] The ‘core-loop’ is composed of the
positive-limb Period-Arnt-Sim (PAS) domain basic helix-loop-helix (PAS-bHLH)
family of transcription factors Brain and Muscle Arnt-like protein-1 (Bmal1) and
Circadian Locomotor Output Cycles Kaput (Clock) and the negative-limb Period
(Per1,2,3) and Cryptocrome (Cry1,2) gene families (Figure 2).[50, 51] BMAL1 and
CLOCK protein, oscillate in a circadian fashion, reach peak expression near the
middle of the inactive phase, heterodimerize, and target E-box elements (5’CACGTG-3’) within the proximal promoters of the Per and Cry genes.[52] Inversely,
PER and CRY proteins reach peak expression toward the middle of the active phase,
heterodimerize, and inhibit BMAL1:CLOCK activity.[53] Upon ubiquitin mediated
degradation of PER and CRY proteins the 24-hour cycle is complete, and ready to
begin again. The ‘alternative’ interlocking loop is comprised of the Rev-erb and Rora
gene families that are also targets of BMAL1:CLOCK.[54, 55] When REV-ERB and
RORA proteins reach peak expression they target Rev-erb Response Elements
(ROREs) within the promoters of the Bmal1 and Clock genes, and repress (REVERBs) or activate (RORAs) gene expression.[56, 57] This alternative loop is thought
to provide stability to the rhythmic expression of Bmal1 and Clock, while also
serving as an integrator of environmental information (i.e. nutrient status) that
temporally aligns the clock to the local environment. Genetic disruption of the core
interlocking loop genes (Bmal1, Clock, Per, Cry) results in behavioral arrhythmias,
while disruption of the alternative loop genes (Rev-erb, Rora) alters the periodicity
of the rhythm.[49]

6

REV-ERB’s

ROR’s

Ror’s
Rev-erb’s

Bmal1

Clock

RORE

BMAL1 CLOCK

E-BOX

Clock-Controlled Genes

Per’s
Cry’s

PER’s CRY’s

Figure 2. Model of the core and alterative interlocking loops of the molecular
clock. BMAL1:CLOCK heterodimers target E-box elements in proximal
promoter regions of Period and Cryptochrome gene families to drive expression of the negative limb transcription factors. Upon transcription/translations Period and Cryptochrome proteins heterodimerize and translocated
into the nucleus where they inhibit BMAL1:CLOCK activity at the protein
level. BMAL1:CLOCK also drive the expression of the alternative limb composed of the Rev-erb and RORA gene families that target ROREs in the
promoters of Bmal1 and Clock to repress and activate gene expression,
respectively.
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1.2.2 Clock-Controlled Genes
The molecular-clock temporally modulates gene expression to generate a protein
expression pattern that peaks at a single time-point throughout a 24-hour period.
The convergence of expression of functionally related proteins ensures that peak
rates of biochemical and physiological processes are temporally aligned with
predictable changes in the environment.

Genes that are direct targets of the

molecular-clock, but lack the ability to modulate the timing mechanism are referred
to as ‘clock-controlled genes’ (CCG). The molecular-clock promotes circadian gene
expression through multiple distinct mechanisms. The most commonly studied
mechanism is the transactivation of genes by the positive-limb transcription factors
BMAL1:CLOCK.

These transcription factors target E-box elements in proximal

promoter elements, and drive gene expression to peak at the transition from the
inactive to active-phase (~CT 12.0).[58, 59] Protein expression typically follows that
of the mRNA so that the proteins encoded by genes directly targeted by
BMAL1:CLOCK are most highly expressed during the active-phase. Chromatinimmunoprecipitation sequencing (ChIP-Seq) studies in peripheral tissues have led
chronobiologists to estimate that roughly 10% of the actively transcribed genes are
target by BMAL1:CLOCK in their promoter regions.[60, 61] Additionally, substantial
portions of CCGs are transcriptional activators/repressors themselves providing an
additional layer of circadian clock output. In addition to their role in stabilizing the
molecular-clock, the Rora and Rev-erb gene families, regulate CCGs by targeting
ROREs in the promoters of genes to rhythmically activate or repress gene
expression, respectively.[62] REV-ERBs have an important role in regulating
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metabolic timing as they have been shown to repress lipogenic genes during the
active-phase.[63, 64] By repressing gene express during the active-phase, many
REV-ERB targets display expression patterns that peak during the inactive-phase
(anti-phasic to that of BMAL1:CLOCK targets). Many additional mechanisms of
clock-output have been observed, but will not be discussed here as they are outside
the scope of this dissertation. Interestingly, temporal gene expression experiments
in peripheral tissues have revealed that the molecular-clocks promote the circadian
expression of CCGs in a tissue specific manner.[41, 61, 65] It is clear that the tissuespecific output of the molecular-clock allows for the temporal control of tissuespecific genes in peripheral tissues, many of which are rate-limiting enzymes in
biochemical pathways, but currently little is understood about the molecular basis
for this phenomenon.

1.3 The Skeletal Muscle Molecular-Clock
Multiple studies have demonstrated the existence of a robust molecular-clock
mechanism in skeletal muscle.[66-75] To identify genes and processes regulated
downstream of the molecular-clock investigators have studied genetic molecularclock mutant mouse models.[60, 76, 77] Initial studies relied on the utilization of
“germ-line” knockout models in which core-clock genes were disrupted or ablated
in every cell throughout the body.[78-81] Characterization of the skeletal muscle of
the germ-line Bmal1 knockout (BMAL1-/-) and ClockΔ19 mutant mice revealed
significant decreases in maximal specific-force generation in both models.[66, 69,
74] The ClockΔ19 mice contain an antimorphic mutation that results in the deletion
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of exon-19 of the Clock gene that encodes for the activation domain of the
protein.[82] Electron microscopy imaging of skeletal muscle from these germ-line
models displayed disruptions in myofilament organization, suggesting a possible
role of the molecular-clock in regulating muscle structure and fuction.[66] Multiple
studies have demonstrated that Bmal1 is required for skeletal muscle
development.[83, 84] Interpretation of the phenotypes present in the germ-line
mouse models is troublesome since these mice lack a functional molecular-clock
throughout all tissues, and at all developmental stages. Therefore, it is difficult to
discern whether the disruption of the molecular-clock is directly responsible for the
skeletal muscle phenotypes observed in these germ-line knockout models.

To

address the confounding factors associated with the germ-line knockout mice, our
lab and others have recently generated inducible skeletal muscle specific Bmal1
knockout mouse models.

1.4 Scope of Thesis: Part 1 (Chapter 2)
The intrinsic molecular-clock is most known for its role in regulating the timing of
cellular metabolism in peripheral tissues, even under constant conditions. [19-26]
These studies have shown that the molecular-clock temporally regulates the
rhythmic activation and/or repression of rate-limiting metabolic genes to help the
cell anticipate changes in environmental conditions and metabolic demand. [27][85]
The capacity of the molecular-clock to regulate metabolism is highlighted by the
metabolic phenotypes observed in genetic clock mutant models.[63, 64, 81, 86-89]
The ClockΔ19 mice develop obesity as well as elevated blood-glucose levels, while
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the Bmal1-/- mice display impairments in glucose handling and gluconeogenesis.[90]
Chip-Seq analysis of REV-ERBα in liver tissue has demonstrated REV-ERBα binding
on a large number of lipid-metabolic genes.[91, 92] Double knockout models in
which Rev-erbα and Rev-erbβ are ablated display disruptions in circadian behavioral
patterns and core-clock gene expression.[92] The Rev-erb double-knockout mice
display hyperglycemia and increased circulating triglycerides. Interestingly, these
mice display a decrease in the respiratory exchange ratio indicative of a shift from
carbohydrate to lipid metabolism.[64] The authors suggested that the shift in
metabolism to a more oxidative-state was caused by an increase in lipid metabolic
gene expression due to the loss of REV-ERB mediated repression.[64]
Identifying the circadian gene expression profile in skeletal muscle is fundamental
to understanding how the molecular-clock regulates physiological processes.[45]
Miller et al. were the first to identify the circadian skeletal muscle
transcriptome.[71] This group performed a time-course micro-array analysis by
isolating RNA from skeletal muscle every 4-hours for 48-hours (2 full circadian
cycles), and subsequently performed micro-array analysis at each time-point. To
accurately distinguish bona fide circadian genes from that of outliers within
inherently noisy time-course micro-array datasets requires the utilization of
powerful circadian statistical approaches. Miller et al. used the circadian statistical
algorithm known as COSOPT that fits temporal gene expression profiles to a cosine
waveform. By comparing the temporal expression pattern of a circadian guide gene
(e.g. Per2), Miller et al. established a ‘goodness of fit’ score they used to set a
statistical cut-off for identifying circadian genes. The goodness of fit score was
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calculated by employing a multiple-measures corrected-Β (MMC-β), and was set to
MMC-β≤0.2 for this study. 267 genes of the 7,824 genes expressed in wild-type
(C57Bl6) skeletal muscle were identified as circadian (MMC-β≤0.2). Functional
gene-ontology analysis of the Miller circadian muscle transcriptome demonstrated
that

the

largest

circadian

gene

clusters

included

genes

involved

in

biosynthesis/metabolism, transcriptional regulation, and cell-cycle regulation.
McCarthy et al. were the next group to generate a skeletal muscle circadian
transcriptome.[70] Their experimental approach was very similar to that of Miller et
al., as they performed micro-array analysis every 4-hours for 48-hours and used the
COSOPT algorithm to identify circadian transcripts in skeletal muscle. In contrast to
Miller et al., McCarthy et al. considered transcripts to be circadian if they displayed a
20-28 hour period length and were under the goodness of fit score: MMC-β≤0.15.
This analysis resulted in the identification of 215 circadian genes in skeletal muscle.
Notable gene-ontology clusters included regulation of protein/lipid metabolism as
well as transcriptional regulation. Interestingly, McCarthy et al. identified a handful
of muscle-specific circadian genes including: Myod1, Ucp3, Atrogin1, Pdk4, and Myh1.
Andrews et al. validated the myogenic regulatory factor, Myod1, as a bona fide
BMAL1:CLOCK target, providing additional evidence that the molecular-clock plays
a role in skeletal muscle development and function.[66]
These initial transcriptome studies provided a fundamental framework to our
understanding of circadian gene regulation in skeletal muscle, but vastly underrepresented the number of oscillating transcripts. The circadian genes identified in
these studies amounted for only ~3% of the total skeletal muscle transcriptome, a
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number that is lower than one would predict from the BMAL1 ChIP Seq studies (1015% coverage of expressed genes).[60] This discrepancy may be explained by the
technological and/or experimental limitations of these initial transcriptome studies.
The Miller and McCarthy studies utilized gene arrays that are less sensitive than the
Affymetrix gene Chips now available.

In addition, these groups employed the

COSOPT statistical algorithm to identify circadian genes, which has since been
demonstrated as less sensitive and specific for the detection of rhythmic transcripts
in comparison to the JTK_CYCLE algorithm. The JTK_CYCLE algorithm is a fusion of
two powerful, non-parametric statistical tests called Jonckeere-Tepstra (JT) and
Kendall’s Tau. JTK_CYCLE employs the JT statistic to detect monotonic orderings
within independent groups. This test compares the expression at of each circadian
time-point in relation to each other, and assigns a positive or negative sign. In effect,
a matrix is generated for each microarray probset depending on the pattern of
expression throughout the experimental time series. Previous statistical algorithms,
such as COSOPT, identify rhythmic gene expression by curve fitting the
experimental time-series to a cosine waveform.

This was accomplished by

determining the inter-group differences between the experimental time-series and
the cosine waveforms.

In contrast, JTK_CYCLE utilizes a ‘look-up’ function to

compare the Kendall’s tau rank correlation coefficient between the experimental
time series matrix, and the matrices from all possible cosine waveforms within the
range of user-defined period lengths. Through the use of the Harding algorithm,
JTK_CYCLE can rapidly and efficiently determines the optimal combination of phase
and period length that provides the lowest possible Kendall’s Tau correlation. Since
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the Kendall’s tau depends only on the sign of the inter-group differences between
circadian time-points this algorithm is very resistant to outliers, and the analysis of
logarithmically transformed data does not alter its ability to efficiently determine
the optimal period and phase. The ability to provide permutation-based p-values
and q-values makes JTK_CYCLE more statistically powerful and computationally
efficient than the previous circadian statistical algorithms.

Quite possibly the

biggest limitation of the initial circadian transcriptome studies is the low sampling
frequency (every 4-hours for 48-hours). The most recent skeletal muscle circadian
transcriptome generated by Hogenesch et al. has an improved statistically power for
the detection of circadian transcripts due to a doubling in the sampling
frequency.[27] Hogenesch et al. performed micro-array analysis every 2-hours for
48-hours. As is described in section 2.2.1 below, we employed the use of JTK_CYCLE
for our analysis of the Hodgenesch skeletal muscle transcriptome and identify
approximately 1,628 genes (8x that of the previous transcriptomes).[93]
An additional benefit of the JTK_CYCLE algorithm is its ability to determine the
acrophase of each circadian gene.[94] We hypothesized that genes involved in
metabolic processes in skeletal muscle would be temporally clustered over a 24-hour
period. We sought to test this idea by identifying the acrophase of genes with
common ontologies, to assist in predicting the potential timing of metabolic
processes in skeletal muscle. As will be shown in chapter 2, the acrophase analysis
of the metabolic genes within the Hogenesch skeletal muscle transcriptome showed
that catabolic and anabolic processes are temporally separated. To our knowledge,
we are the first to propose an in-depth molecular mechanism to describe how
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metabolic processes are temporally regulated. These findings will be of particular
interest to the skeletal muscle and metabolism fields since skeletal muscle is such a
large tissue and is the main sight of post-prandial glucose uptake, as well as aminoacid storage.
To further elucidate genes and physiological processes regulated by the molecularclock many investigators have performed transcriptional analyses of peripheral
tissues with genetically disrupted clocks. Miller et al. and McCarthy et al. performed
micro-array analyses comparing gene expression in wild-type and ClockΔ19 skeletal
muscle.[70, 71] Miller et al. showed that approximately 78% of the genes they
identified as circadian displayed significantly different expression values in the
ClockΔ19 mouse model with the majority of genes exhibiting significantly decreased
expression. This group did not provide a detailed description of the circadian genes
that were down-regulated in the ClockΔ19 skeletal muscle, although they did note
that previously identified CCGs such as Dbp and Per2 were significantly downregulated. McCarthy et al. observed similar findings with the ClockΔ19 skeletal
muscle as they reported changes in the expression pattern of approximately 30% of
the circadian transcriptome, but do not provide a detailed analysis of these genes.
Although these studies demonstrate large scale disruptions of the circadian genes in
the ClockΔ19 skeletal muscle, it is now widely accepted that deletion/mutation of
the Clock gene does not completely ablate molecular and behavioral rhythms as
redundancy in the molecular-clock mechanism functions in the absence of the
CLOCK protein.

The only single knockout model that completely ablates both

molecular and physiological rhythms is the Bmal1-/- knockout model.[50]
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Additionally, the use of the ClockΔ19 mouse model makes it hard to discern whether
the transcriptional changes observed in the skeletal muscle are truly caused by the
intrinsic molecular-clock as these animals lack a functional CLOCK protein
throughout the body and therefore display behavioral arrhythmias.
On-going studies are aimed at utilizing organ-specific molecular-clock mutant
models to determine the function of the clock in each tissue. These studies also
serve to assess the role(s) the peripheral clocks play in regulating whole body
metabolism [39-43].

Dyar et al. have recently developed two skeletal muscle

specific Bmal1 knockout models to study metabolic changes.[68] The two models
consist of a Bmal1 knockout model from birth (Bmal1flox/flox x Mlc1f-Cre), called mKO,
and a tamoxifen inducible Bmal1 knockout model (Bmal1flox/flox x Acta1-Cre), called
imKO. The mKO mice displayed decreases in specific force generation while the
imKO mice did not show any significant decrease in specific force generation, and
this discrepancy may be explained by developmental differences caused by the loss
of Bmal1 at birth.

This group demonstrated a significant decrease in insulin-

stimulated glucose uptake in isolated soleus muscle in both the mKO and imKO
models compared to age-matched wildtype controls (basal levels unaffected). Dyar
et al. attributed the impairments in insulin-stimulated glucose uptake to the marked
reduction in the expression of the muscle specific glucose transporter GLUT4, and a
reduction in the activity of Pyruvate Dehydrogenase (PDH) responsible for
regulating the flux of carbohydrates into the TCA-cycle. Since the mKO and imKO
models display normal circadian activity patterns, the impairments in glucose
handling can be attributed to the intrinsic skeletal muscle clock. In agreement with
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the results reported by Dyar et al., analysis of our inducible muscle specific Bmal1
knockout model resulted in circadian genes involved in glucose and lipid handling
being down and up-regulated, respectively.

1.4.1 Scope of Thesis: Part 2 (Chapter 3)
Previous studies have sought to elucidate the transcriptional mechanisms regulating
the Titin-cap (T-cap) gene given its functional importance in striated muscle, and its
roles in Limb-Girdle muscular dystrophy type 2G and dilated cardiomyopathy.[9599] The T-cap protein forms one of the strongest known non-covalent proteinprotein interactions in the body through hydrogen binding of the Z1-Z2 N-terminal
domains of adjacent Titin molecules to effectively link two sarcomeres at the Z-line.
[95] T-cap is highly expressed in both skeletal muscle and the heart.[98] The
proximal promoter region of the T-cap gene contains multiple E-box elements that
are highly conserved between humans and mice and suggests the regulation of this
gene by bHLH transcription factors.[99] The myogenic regulatory factor MYOD1 has
been shown to promote the expression of T-cap in both porcine and mouse skeletal
muscle.[97, 99] Podobed et al. showed that T-cap is regulated down-stream of the
molecular-clock in mouse heart tissue as its mRNA and protein oscillate in wild-type
mice, and are down-regulated in ClockΔ19 heart tissue.[96] This group
demonstrated the ability of BMAL1:CLOCK to promote T-cap promoter:luciferase
activity and observed BMAL1 binding on the T-cap proximal promoter at a highly
conserved tandem E-box element (E-box-xxxxxx-E-box).

Further analysis is

required to determine if the Titin-bound portion of T-cap oscillates over time of day.
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As stated earlier, there is a very limited knowledge of the mechanisms responsible
for tissue-specific regulation of CCGs. In an attempt to study this phenomenon in
skeletal muscle, we sought to first identify a muscle specific CCG by performing a
bioinformatics analysis that ultimately led to the identification of T-cap as a
circadian gene in skeletal muscle. Since previous studies have validated T-cap as a
BMAL1:CLOCK target (heart tissue) as well as its regulation by MYOD1, we decided
to investigate the transcriptional regulation of T-cap as a model for CCG regulation
in skeletal muscle. Our study validates T-cap as a CCG in skeletal muscle and reveals
a previously unidentified mechanism in which MYOD1 works synergistically with
the molecular-clock to promote the circadian expression of T-cap.

2 Chapter 2: The endogenous molecular clock orchestrates the temporal
separation of substrate metabolism in skeletal muscle
Text and figures in this chapter are adapted from the first author manuscript: The
endogenous molecular clock orchestrates the temporal separation of substrate
metabolism in skeletal muscle. Hodge et al., Skeletal Muscle 2015.[93]
Author Contributions: BAH participated in the time-course collection and RNA
extraction from iMS-Bmal1 muscle tissue, contributed to the recombination assay,
carried out the bioinformatics analysis, and drafted the manuscript. YW participated
in the bioinformatics analysis, contributed to the interpretation of the data,
generated the heat-map, and helped with the writing of the manuscript. LAR helped
with the bioinformatics analysis and figure production. JHE participated in the timecourse collection and preparation of the RNA used in the microarray assays. BDH
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and EAS participated in the time-course collection and completed the mouse activity
data collection and analysis. EAS also carried out the real-time PCR analysis and
participated in the recombination assay. XZ participated in the time-course
collection and performed the Western blot analysis. KAE was involved in the design
and coordination of the study and helped with the drafting of the manuscript.

2.1 Introduction
Skeletal muscle plays a large role in whole-body metabolism as it constitutes
approximately 40% of body mass and is a highly metabolically active tissue.[100,
101] Basal metabolic rate is dependent on both the size and activity of skeletal
muscle as cross-bridge cycling and calcium handling associated with contraction are
energetically expensive processes.[101-104] Skeletal muscle is a principle
contributor to whole-body glucose handling as it is responsible for approximately
80% of postprandial glucose uptake.[105, 106] It has been widely reported that
skeletal muscle has regulatory mechanisms that modulate substrate utilization and
storage in response to varying metabolic demands and environmental conditions
(for example, nutrient status).[102, 107-111] For instance, skeletal muscle rapidly
modulates rates of glucose uptake and utilization in response to contraction and/or
insulin stimulation.[112-114] While the fluctuations in the role for muscle to store
vs. use is commonly linked with the fed/fasted and active/inactive behaviors, these
changes in storage and use are also aligned with the 24-h (circadian) light/dark
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cycles attributed to the rising and setting of the sun and feeding/activity
behavior.[115]
Utilizing high-resolution temporal transcriptome data coupled with circadian
statistics has proved to be an effective method for identifying genes expressed in a
circadian manner.[116, 117] In the present study, we employ a bioinformatics
approach with a publically available high-resolution circadian data set collected
under constant dark conditions to analyze the skeletal muscle circadian
transcriptome (gastrocnemius muscle) with a focus on the temporal phase of gene
expression. We reveal that skeletal muscle circadian genes are highly enriched for
metabolic processes, and furthermore, we identify the temporal pattern of peak
expression for different key metabolic genes separating catabolic vs. anabolic
processes over 24 h. To identify which circadian-metabolic genes are regulated
downstream of the intrinsic molecular clock, we generated an inducible musclespecific Bmal1 knockout (iMS-Bmal1−/−) mouse and performed a time series
transcriptome analysis. Mice lacking Bmal1 in skeletal muscle displayed no
apparent changes in circadian behavior, yet we observed significant decreases in the
expression of circadian genes involved in glucose utilization and adrenergic
signaling, while observing significant increases in lipogenic genes. Consistent with a
substrate shift from carbohydrate to lipid utilization, we observed a concomitant
shift from a fast to slow fiber-type gene expression profile indicative of a more
oxidative muscle in iMS-Bmal1−/−. These findings demonstrate that the endogenous
molecular clock in skeletal muscle contributes significantly to the time of day shifts
in carbohydrate/lipid metabolism.
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2.2 Materials and Methods
2.2.1 High-resolution circadian microarray
Microarray data for the high-resolution circadian time-course are from
gastrocnemius muscles of male C57Bl6 mice collected every 2 h for 48 h under
constant dark conditions and ad libitum food availability.[27] The data were
downloaded from NCBI GEO datasets (GSE54652) and consist of 24 individual
arrays, one for each time point from circadian time 18 to 64.[117] Expression
intensities from the series matrix file for all probesets at all time points were used
as input for JTK_CYCLE analysis, with period length set to 24 h.[94] We defined
circadian genes as having a JTK_CYCLE adjusted P value of less than 0.05. We
utilized the Bioconductor package to identify mapped probesets on the Affymetrix
Mouse Gene 1.0ST chip that represent unique genes, thus eliminating control
probesets from further analyses. Genes with median expression intensities of at
least 100 were considered as expressed in skeletal muscle. We entered the list of
circadian genes into Gene Ontology Consortium online tools to identify enriched
biological processes.[118, 119] Enrichment P values were adjusted for multiple
testing using Bonferroni correction.

2.2.2 Inducible skeletal muscle -specific Bmal1 inactivation mouse model
All animal procedures were conducted in accordance with institutional guidelines
for the care and use of laboratory animals as approved by the University of
Kentucky Institutional Animal Care and Use Committee. The floxed Bmal1 mouse
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[B6.129S4(Cg)-Arntltm1Weit/J] was purchased from The Jackson Laboratory and has
no reported breeding, physical, or behavioral abnormalities.[120] The skeletal
muscle-specific Cre-recombinase mouse, [human skeletal actin (HSA)-MerCreMer]
has been previously characterized.[121] The floxed Bmal1 mouse has loxP sites
flanking exon 8 and is indistinguishable from wild-type littermates. Breeding with
the skeletal muscle-specific Cre-recombinase mouse generates offspring in which
selective deletion of the bHLH domain of Bmal1 in skeletal muscle can be induced
upon tamoxifen administration. Inducible skeletal muscle-specific Bmal1 knockout
mice were generated as follows: the Bmal1flox/flox female was crossed with the
skeletal muscle-specific Cre-recombinase male. This yielded an F1 generation of
skeletal muscle-specific Cre+/−;Bmal1+/flox mice. Breeding the F1 generation males to
the Bmal1flox/flox females resulted in the skeletal muscle-specific Cre+/−;Bmal1flox/flox
mice (referred to as iMS-Bmal1flox/flox) needed for this study. Mouse genotypes were
determined by PCR using genomic DNA isolated from tail snips. Activation of Crerecombination was done by intraperitoneal injections of tamoxifen (Sigma-Aldrich,
St. Louis, MO, USA; Cat. No. T5648) (2 mg/day) for five consecutive days when the
mice reached 12 weeks of age. This age was chosen to eliminate any effects that the
lack of Bmal1 might have on skeletal muscle development and postnatal maturation.
Controls were vehicle (15% ethanol in sunflower seed oil)-treated iMS-Bmal1flox/flox
mice.
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2.2.3 Recombination specificity
The iMS-Bmal1 mice were injected (intraperitoneal) with either vehicle (iMSBmal1+/+) or tamoxifen (iMS-Bmal1−/−) between 12 and 16 weeks of age. Five weeks
postinjection, mice were anesthetized with isoflurane, and the heart, diaphragm,
liver, lung, abdominal aorta, brain, tibialis anterior, soleus, gastrocnemius, brown
fat, white fat, and cartilage were collected and immediately frozen in liquid nitrogen
for DNA analysis. Genomic DNA was extracted from the tissues using the DNeasy
Blood and Tissue Kit (Qiagen, Venlo, Netherlands). To assess recombination
specificity, PCR was performed with tissue DNA and primers for the recombined and
non-recombined alleles as described in Storch et al.[120] The forward and reverse
primers for the non-recombined allele were the same as the genotyping primers and
yielded

a

431-bp

product.

A

second

forward

primer

5′-

CTCCTAACTTGGTTTTTGTCTGT-3′ was included to detect the recombined allele,
which showed a band at 572 bp [50]. The PCR reaction was run on a 1.5% agarose
gel (0.0005% ethidium bromide) to visualize the DNA products.
2.2.4 RNA isolation and real-time PCR
Total RNA was prepared from frozen gastrocnemius tissue samples using TRIzol
(Invitrogen) according to the manufacturer’s directions. RNA samples were treated
with TURBO DNase (Ambion, Austin, TX, USA) to remove genomic DNA
contamination. Isolated RNA was quantified by spectrophotometry (λ = 260 nm).
First-strand cDNA synthesis from total RNA was performed with a mixture of
oligo(dT) primer and random hexamers using SuperScript III First-Strand Synthesis

23

SuperMix (Invitrogen, Waltham, MA, USA). All isolated RNA and cDNA samples were
stored at −80°C until further analysis. Real-time quantitative PCR using TaqMan
(Applied Biosystems, Waltham, MA, USA) assays was used to examine the gene
expression of Bmal1 (Mm00500226_m1), Rev-erbα (Mm00520708_m1), Dbp
(Mm00497539_m1), Hk2 (Mm00443385_m1), Pdp1 (Mm01217532_m1), Fabp3
(Mm02342495), and Pnpla3 (Mm00504420_m1). The ΔΔCT method was used for
the quantification of real-time PCR data in the circadian collections.

2.2.5 Wheel activity monitoring
One cohort of mice was used for analysis of circadian behavior (gene expression not
analyzed in this cohort). A total of 20 mice (mixed genders) were analyzed with 11
receiving tamoxifen treatment and the remaining 9 receiving vehicle treatment. The
mice were maintained in individual cages with a running wheel under 12 L:12D
(LD) conditions for 4 weeks. The wheel running of the vehicle (iMS-Bmal1+/+) or
tamoxifen (iMS-Bmal1−/−) mice were continuously recorded and monitored
throughout the experiment using ClockLab software.[122] To determine the freerunning period of the mice, we released them into total darkness (DD) for 3 weeks.
Activity was evaluated using voluntary running wheel rotations plotted in 1-min
bins. The free-running period (tau) during the 3-week DD period was calculated
using periodogram analysis in the ClockLab software.
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2.2.6 Circadian collections
Forty-eight iMS-Bmal1flox/flox mice were housed in individual cages in light boxes,
entrained to a 12-h LD cycle for 14 days, and had ad libitum access to food and
water. Following the 2-week entrainment period, 24 mice were injected with vehicle
and 24 with tamoxifen for five consecutive days, generating 24 iMS-Bmal1+/+ and 24
iMS-Bmal1−/− mice, respectively. The light schedule was kept the same during
injections and for the subsequent 5 weeks. Five weeks after the last day of
injections, mice were released into constant darkness for 30 h following protocols
established in the circadian field.[27, 70] Mice were sacrificed in darkness (dim red
light), and skeletal muscle s were collected every 4 h for 20 h (six time points) and
frozen for RNA and protein analysis.
2.2.7 Microarray analysis of iMS-Bmal1+/+, iMS-Bmal1−/−, and MKO (Dyar et al.)
We pooled equivalent amounts of total RNA from four mice for each time point
(circadian time 18, 22, 26, 30, 34, 38) and treatment (vehicle or tamoxifen). Pooled
RNA samples were used to construct cDNA libraries that were hybridized to
Affymetrix Mouse Gene 1.0ST microarrays (Affymetrix, Santa Clara, CA, USA) (1
sample/time

point).

Intensity

data

for

iMS-Bmal1+/+

and

iMS-Bmal1−/−

gastrocnemius muscles are quantile normalized, and a low pass median intensity
filter of greater than or equal to 100 is applied to both iMS-Bmal1+/+ and iMSBmal1−/− datasets separately. Nine thousand one hundred eighty-four nonredundant, mapped genes (9,988 probesets) are considered to be expressed in one
or both datasets. Gene expression changes in iMS-Bmal1−/− muscle tissue were
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calculated by averaging the change in expression for each gene throughout the
circadian time course (CT18-38, n = 6). Tibialis anterior and soleus gene expression
values for control and muscle-specific knockout model (MKO) from Dyar et al.[68]
were downloaded from NCBI GEO datasets (GSE43071) and consists of 18
individual arrays, three for each time point from circadian time 0 to 20. To compare
temporal gene expression changes for the TA and SOL, we averaged Affymetrix ST
1.0 expression values for each gene at circadian times 0, 4, 8, 12, 16, and 20.
Student’s t test was used to identify differentially expressed probesets at a
significance of P ≤ 0.05.

2.2.8 Western blot
Whole cell lysates were prepared from the liver and gastrocnemius of iMS-Bmal1+/+
and iMS-Bmal1−/− mice (n = 3/strain). SDS-PAGE (4-15% separating gel, Bio-Rad,
Hercules, CA, USA) and immunoblotting were carried out with routine protocols.
Affinity-purified Bmal1 polyclonal antibody (Sigma-Aldrich, SAB4300614) was
visualized with IRDye-conjugated secondary antibody using the Odyssey system (LiCor, Lincoln, NE, USA). Each lane contained 50μg total protein.
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2.3 Results and Discussion
2.3.1 Cellular metabolic processes are highly enriched in the circadian
transcriptome of skeletal muscle
To identify circadian gene expression in skeletal muscle , we used a publicly
available,

high-resolution,

circadian

time-course

microarray

dataset

from

gastrocnemius muscles of male C57BL/6 mice.[27, 117] These mice were housed in
constant darkness, and food was provided ad libitum to eliminate the influence of
external environmental cues. We chose this dataset because it has double the
sampling frequency of previously published circadian muscle transcriptomes, and
this allows for greater precision for circadian analysis.[27, 123] Using the
JTK_CYCLE statistical algorithm [94] for the reliable detection of oscillating
transcripts with a 24-h periodicity, we identified 1,628 circadian mRNAs (adjusted P
< 0.05). An unbiased Gene Ontology enrichment analysis of these circadian genes
revealed a significant overrepresentation of cellular metabolic processes, with
approximately 1,004 (62%) genes directly involved in skeletal muscle metabolic
processes as well as the regulation of metabolism (Figure 3).
Herein, we report the acrophase according to their respective circadian times (CT),
which is standardized to the free-running period of the mice under constant
conditions. For the array studies, the mice were only in DD for 30 h so CT 0 denotes
the start of the inactive period, while CT 12 denotes the start of the active period. To
identify the timing of gene expression and its relationship to metabolic processes in
skeletal muscle, we annotated a subset of circadian genes by their known functions,
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positive regulation of metabolic process (GO:0009893)

regulation of macromolecule metabolic process (GO:0060255)

cellular process (GO:0009987)

single-organism process (GO:0044699)

positive regulation of cellular process (GO:0048522)

negative regulation of biological process (GO:0048519)

negative regulation of cellular process (GO:0048523)

positive regulation of biological process (GO:0048518)

primary metabolic process (GO:0044238)

regulation of primary metabolic process (GO:0080090)

organic substance metabolic process (GO:0071704)

regulation of cellular metabolic process (GO:0031323)

regulation of metabolic process (GO:0019222)

cellular metabolic process (GO:0044237)

metabolic process (GO:0008152)
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Ratio

-log(P Value)
41

Enriched GO Terms for Biological Processes
0.14

0.12

29
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Figure 3. Gene ontology analysis of the skeletal muscle circadian transcriptome. Top 15 enriched GO processes listed from left to right in order of signi�icance.

timing of peak expression, and involvement in key metabolic pathways. We focused
our analysis on metabolic functions that involve substrate (carbohydrate and lipid)
utilization as well as storage and biosynthetic processes.
2.3.1.1 Lipid metabolism: genes involved in fatty-acid uptake and β-oxidation peak
in the mid-inactive/light phase
Skeletal muscle expresses specialized membrane transporters to facilitate the
transport of lipids into the cell.[124-126] Two lipid transport genes that encode for
fatty-acid binding proteins, Fabp4 (CT 24.0) and Fabp3 (heart/muscle isoform, CT
6), are expressed in a circadian manner with the highest mRNA expression in the
early- and mid-inactive periods, respectively. Acrophase of circadian genes involved
in lipid metabolism are illustrated in Figure 4. Normalized expression traces for
each gene are located in Appendix Files 1 and 2. Previous studies have
demonstrated oscillations in plasma fatty acid concentrations in mice with peak
levels occurring during the inactive/light period.[92, 127, 128] Further functional
analysis is required to validate the prediction that the rate of fatty-acid uptake in
skeletal muscle peaks during the mid-late inactive period. Upon uptake into the cell,
fatty acids can be stored as triglycerides or be converted to acetyl-CoA through βoxidation.[129] Slc25a20 encodes for an acyl-carnitine translocase that transfers
fatty acids into the inner-mitochondrial matrix and reaches peak expression in the
middle of the inactive period (CT7.5).[130] We identified multiple genes that encode
for β-oxidation enzymes to be circadian and also reach peak expression around the
mid-inactive phase. These include the enoyl CoA hydratase Ech1 (CT 7.0), the tri-
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Figure 4. Schematic acrophase diagram of circadian genes involved in lipid
metabolic processes. The relative location of the circadian genes(italicized) in
respect to the x-axis indicates acrophase or time of peak expression calculated
by the JTK_CYCLE algorithm. Location of substrates and pathways does not
represent peak substrate concentrations and/or rates of individual pathways
as these were not measured in our analysis. White/grey shading is representative of the inactive and active phases, respectively.
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functional enzyme subunits Hadha (CT 8.0) and Hadhb (CT 8.0), and the acetyl-CoA
acyltransferase Acaa2 (CT 9.0). Malonyl-CoA, an intermediate formed during de
novo fatty acid synthesis, is a potent inhibitor of β-oxidation. The striated muscle
enriched gene Mlycd (CT 7.5) encodes for the malonyl-CoA decarboxylase that
promotes β-oxidation by reducing cytosolic concentrations of malonyl-CoA and
reaches peak expression during the mid-inactive period similar to that of the
circadian β-oxidation genes. These observations suggest that rates of β-oxidation
are modulated over time of day and potentially through the endogenous molecular
clock in skeletal muscle.[109, 131, 132]
Nuclear receptors are known to be potent transcriptional regulators of metabolism
as they sense changes in environmental conditions and induce appropriate changes
in the expression of metabolic genes.[133-137] The nuclear receptor Estrogenrelated receptor alpha (Esrra, CT 7.5) and the nuclear co-activator PPARγ
coactivartor-1 beta (Ppargc1b, CT 7.0) are both circadian genes in skeletal muscle
with peak expression occurring at the mid-inactive phase. These factors have been
shown to promote mitochondrial biogenesis, fatty-acid uptake (targets Fabp3), and
β-oxidation.[138, 139] The nuclear co-repressor Nrip1, also known as Rip140, is a
potent negative regulator of skeletal muscle oxidative metabolism and has been
shown to suppress expression of the fatty-acid transporter, Fabp3, in skeletal
muscle .[140-142] NRIP1 suppresses gene expression by binding nuclear receptors
(including PPARs and estrogen-related receptors) and recruiting histone
deacetylases.[143] Interestingly, peak expression of Nrip1 occurs during the
beginning of the active period (CT 13.0) and may therefore act as a molecular brake
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to oxidative metabolism as the muscle transitions from lipid to carbohydrate
utilization during the early active phase.
2.3.1.2 Lipid metabolism: lipogenic genes reach peak expression at the end of the
active/dark phase
The lipogenic genes Acly (CT23.0), Acaca (CT 23.0), and Fasn (CT 22.5) involved in
de novo fatty-acid synthesis, or the conversion of excess carbohydrates into fatty
acids, reach peak expression at the end of the active phase (Figure 4).[129, 144]
Scd1 (CT 24.0) encodes the enzyme that catalyzes the rate-limiting reaction of
monounsaturated fatty-acid formation to promote lipid bilayer fluidity and
lipogenesis.[145, 146] The genes Srebf1 (CT 24.5), Srebf2 (CT 24.0), and Mlxip (CT
23.5) encode transcription factors that target carbohydrate response elements
within lipogenic gene promoter regions (Acly, Acaca, and Fasn) and are also
circadian with peak expression at the end of the active phase.[147, 148] Consistent
with our results, Srebf1 oscillations have been reported in the liver and genomewide binding studies have shown a circadian recruitment pattern of SREBF1 to the
promoters of lipogenic genes with maximal binding during the active (fed)
stage.[149-152]
The gene Pnpla3 (CT 21.0), also known as adiponutrin, promotes lipogenesis by
converting LPA to phosphatidic acid (PA).[153] The gene Lpin1 (CT 24.0) which
encodes for the lipin-1 enzyme is responsible for converting phosphatidic acid (PA)
to diacylglycerol (DAG), which is the upstream metabolite required in phospholipid
biosynthesis.[154, 155] The highly regulated, committing step in triacylglycerol
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(TG) synthesis, addition of a fatty-acyl-CoA to DAG, is performed by the product
encoded by Dgat1 (CT 24.5), which is also expressed in a circadian manner.[156]
Once a TG molecule is formed, it can be elongated by enzymes encoded by Acsl5 (CT
23.0) or Elovl5 (CT 22.5).[157, 158] The observation that circadian lipogenic genes
reach peak expression levels around the end of the active phase suggests that
skeletal muscle promotes storage of excess energy at the end of the
active/absorptive phase.
2.3.1.3 Carbohydrate metabolism: genes involved in carbohydrate catabolism peak
in the early active/dark phase
Glycolysis, the breakdown of glucose to form pyruvate, is primarily regulated at two
enzymatic reactions catalyzed by the hexokinase and phosphofructokinase
enzymes.[159] We observe that the hexokinase-2 (Hk2) gene is circadian with peak
expression occurring at the beginning of the active phase (CT 12.0). Acrophase of
circadian genes involved in carbohydrate metabolism are illustrated in Figure 5.
Normalized expression traces for each gene are located in Appendix Files 3 and 4.
Hk2 is responsible for the first step in glycolysis by phosphorylating glucose to make
glucose-6-phosphate, thereby trapping glucose within the cell.[160] The ratelimiting step of glycolysis involves the catalysis of fructose-6-phosphate to the
highly unstable fructose-1,6-bisphosphate by the enzyme phosphofructokinase-1
(PFKM).[161, 162] A potent allosteric activator of PFKM is fructose-2,6bisphosphate, which is the product of the other phosphofructokinase isozyme
phosphofructokinase-2 (PFK2).[163] Three genes (Pfkfb-1,3,4) that encode
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phosphofructokinase-2 subunits are circadian with peak expression occurring
during the mid- and late-inactive phases (CT 10.0, CT 4.5, and CT 12.0, respectively).
Glycolytic flux through the Kreb’s cycle is controlled by pyruvate dehydrogenase
complex (PDH).[164, 165] PDH decarboxylates pyruvate to form acetyl-CoA, which
is a substrate for the Kreb’s cycle. The activity of PDH is regulated at the
posttranslational level. Phosphorylation by kinases (PDKs) inhibits PDH activity,
while dephosphorylation by phosphatases (PDPs) activates the complex.[166, 167]
The Pdk4 gene, which encodes for a PDH kinase that inhibits PDH, reaches maximal
expression at the mid-inactive phase (CT 6.0). This expression pattern is similar to
that of the β-oxidation genes and suggests that skeletal muscle substrate preference
is pushed toward utilization of lipids over carbohydrates during the mid- to lateinactive phase. Conversely, the PDH phosphatase gene, Pdp1, peaks at the beginning
of the active phase (CT 10.0) in a similar temporal fashion compared to the
glycolytic enzymes described above. This temporal regulation of Pdp1 may therefore
help increase glycolytic flux during the active phase. Dyar et al. observed similar
expression patterns of Pdk4 and Pdp1 in skeletal muscle and were first to report a
shift to carbohydrate utilization at the beginning of the active phase.[68]
Adrb2 encodes for the β2-adrenergic receptor (β2AR) involved in the fight-or-flight
response in peripheral tissues.[168, 169] Agonist (that is, catecholamine) binding is
well established to evoke a cell-signaling cascade that promotes glucose uptake,
glycogenolysis, and lipolysis to provide a readily available source of energy for
skeletal muscle.[170-172] Adrb2 is expressed in a similar pattern to that of the
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glycolytic activating genes as it peaks at the beginning of the active phase.
Interestingly, the expression of Adrb2 coincides with that of oscillating epinephrine
concentrations in mammals, which has previously been identified as peaking at the
beginning of the active phase in mouse models.[173] The G-protein receptor kinase,
encoded by Adrbk1, phosphorylates the β2AR, thereby rendering it susceptible to
receptor-mediated endocytosis via β-arrestin proteins encoded by Arrdc3 and
Arrb1.[174-176] Adrbk1, Arrdc3, and Arrb1 are all expressed in a circadian manner
and antiphase to the expression of Adrb2. These observations suggest there is a time
of day difference in adrenergic signaling and that sensitivity to epinephrine may be
highest in skeletal muscle during the active period while being desensitized prior to
the inactive period.
2.3.1.4 Carbohydrate metabolism: genes involved in carbohydrate storage peak at
the mid-active/dark phase
Excess carbohydrates are stored as glycogen in skeletal muscle which accounts for
approximately 70 to 80% of whole body stores.[177] Unlike the liver, skeletal
muscle glycogen content is not responsible for maintaining blood glucose
concentrations but serves as a rapidly accessible energy depot for active
contractions.[170] Glycogenesis is regulated by both glucose-6P concentrations and
the enzymatic activity of glycogen synthase.[178, 179] The gene Ppp1r3c (CT 20.0)
reaches peak expression around the mid-inactive phase and encodes a regulatory
subunit of the protein phosphatase-1 (PP-1) responsible for activating glycogen
synthase while also inhibiting glycogen breakdown (Figure 5).[180] Enzymatic
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activity of PP-1, and subsequent activation of glycogen synthase, is regulated
downstream of the insulin signaling pathway.[181]
Insulin promotes an anabolic signaling cascade that works in opposition to that of
adrenergic signaling to drive glycogen and lipid storage. Previous reports have
identified a ‘counter-regulatory’ role of insulin receptor to selectively inhibit β2AR
signaling through phosphorylation and subsequent internalization of the
receptor.[169, 182] Interestingly, the genes that encode the insulin receptor
substrate-1, Irs1 (CT 22.0), and its downstream PI3-kinase target, Pik3r1 (CT 19.0),
are both circadian with peak expression occurring at the late-active phase while the
genes involved in suppressing PI3-kinase, Pik3ip1 (CT 8.0), and the insulin-receptor
substrate-1, Fbxo40 (CT 5.0), reach peak expression during the inactive phase.[183,
184] These data suggest that the molecular clock may act to prime skeletal muscle
to store excess glucose during the mid- to late-active phase. This prediction is
further supported by previous studies that report skeletal muscle glycogen content
as having a diurnal rhythm with the highest levels occurring during the mid-active
phase.[185-187] Skeletal muscle glucose uptake is primarily controlled via the
presence/absence of the glucose transporter GLUT4/Slc2a4 in the plasma
membrane (sarcolemma) and transverse tubules. A t-SNARE syntaxin-4 interacting
protein, encoded by Stxbp4, has previously been shown to repress GLUT4 insertion
into the plasma membrane in the absence of insulin signaling.[188-190] The gene
Tbc1d1 encodes for Rab-GTPase that represses GLUT4 translocation in the absence
of insulin- or contraction-induced signaling cascades.[191-193] Interestingly,
Tbc1d1 and Stxbp4 are both expressed in a circadian manner and reach peak
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expression in the middle of the active phase (CT 19.0). Previous reports have
identified Tbc1d1 as a circadian gene in skeletal muscle and other tissues.[68, 194]
Together, these gene products may play a role in reducing glucose uptake at the end
of the active phase by repressing GLUT4 translocation and/or insertion into the
plasma membrane. This temporal separation of anabolic and catabolic signaling
processes in skeletal muscle may be vital for maintaining a tight regulation of serum
glucose levels, and disruption of which may contribute to the metabolic phenotypes
often reported in clock-mutant mice models.
2.3.2 Generation of an inducible skeletal muscle-specific mouse model of Bmal1
inactivation
Use of the high-resolution microarray data set allowed for the identification of
mRNAs expressed in a circadian pattern, but this could be due to the intrinsic
molecular clock or could be a response to external behavioral (feeding/activity) or
neural/humoral cues.[195-197] To determine the role of the intrinsic skeletal
muscle molecular clock in the temporal regulation of metabolic gene expression, we
generated an inducible mouse model to inactivate Bmal1 specifically in adult
skeletal muscles. Upon treatment with tamoxifen in 12-week-old adult mice, we
detect recombination of exon-8 (that is, DNA binding region) of the Bmal1 gene
specifically in skeletal muscle (Figure 6A), confirming the tissue specificity of the
mouse model. We waited until 12 weeks of age to limit possible developmental
effects as BMAL1 has been shown to promote myogenesis.[66, 84] As seen in Figure
6A, recombination was not detected in the skeletal muscle or non-muscle tissues of
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Figure 6. Characterization of iMS-Bmal1−/− mice. Recombination assay
(A) of genomic DNA isolated from muscle and non-muscle tissues from
tamoxifen-treated (iMS-Bmal1−/−) and vehicle-treated (iMS-Bmal1+/+)
mice at 17 to 18 weeks of age (5 weeks post-injection). Recombination of
the Bmal1 gene (exon 8) yields a 572-bp PCR product. The non-recombined allele is detected at 431 bp. Western blot (B) analysis of BMAL1
expression in iMS-Bmal1−/− and iMS-Bmal1+/+ liver and gastrocnemius
samples. Note that the original blot containing both muscle and liver samples was cut, and brightness/contrast was altered to enhance the visibility
of Bmal1 in the muscle samples. (C) Real-time PCR results of time-course
expression values for Bmal1, Rev-erbα, and Dbp in the iMS-Bmal1+/+
(black) and iMS-Bmal1−/− (red). Representative wheel running rhythms
(D) of iMS-Bmal1−/− and iMS-Bmal1+/+ mice. White and black bars (top)
indicate light and dark phases. 12 L/12D represents the 12-h light/12-h
dark cycle. 12D/12D represents constant darkness conditions. Tick marks
indicate wheel running activity. Representative chi-squared periodograms
(E) of iMS-Bmal1−/− and iMS-Bmal1+/+ mice indicating approximate 24-h
period lengths in both mice.
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vehicle-treated mice (iMS-Bmal1+/+). Western blot analysis confirmed the depletion
of BMAL1 protein in the skeletal muscle of the iMS-Bmal1−/− mice with no effect on
the liver (Figure 6B). Tamoxifen-induced loss of Bmal1 in adult skeletal muscle
resulted in significant and expected gene expression changes of genes involved in
the core clock mechanism. In particular, genes directly activated by the
BMAL1/CLOCK heterodimer, such as Rev-erbα and Dbp, are markedly downregulated in iMS-Bmal1−/− but not in the iMS-Bmal1+/+ samples (Figure 6C).
Collectively, these results demonstrate the effective loss of BMAL1 protein and
disruption of core-clock gene expression in the iMS-Bmal1−/− muscle tissue.
2.3.2.1 iMS-Bmal1-/- display normal circadian activity rhythms
We used voluntary wheel running to assess circadian behavior in the iMS-Bmal1
mice 22 to 29 weeks post-treatment. We did not detect any significant differences in
entrainment to light under 12-h light/12-h dark conditions between iMS-Bmal1+/+
and iMS-Bmal1−/−, and analysis of activity rhythms under constant darkness did not
reveal any changes in circadian behavior (Figure 6D, E). Clock-lab analysis indicates
that both iMS-Bmal1+/+ and iMS-Bmal1−/− exhibit approximate 24-h period lengths
(23.85 ± 0.083 and 23.77 ± 0.138 h, respectively) with no differences in amplitude,
the relative strength of the rhythm. These data are consistent with other studies and
confirm that inactivation of BMAL1 in skeletal muscle does not directly alter
circadian activity patterns.[68, 198] Therefore, gene expression changes observed in
this model are more likely to be downstream of the endogenous molecular-clock
mechanism in skeletal muscle .
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2.3.3 Expression of key circadian metabolic genes are significantly altered in iMSBmal1−/− skeletal muscle
Gene expression analysis of iMS-Bmal1+/+ and iMS-Bmal1−/− muscle tissue reveals
that the intrinsic molecular clock, even in constant conditions, plays a role in
temporally regulating carbohydrate and lipid metabolism. We performed our
transcriptome analysis at 5 weeks post-recombination to identify early gene
expression changes caused by the loss of the clock mechanism in skeletal muscle.
Analyzing gene expression at this time point also limits potential off-target effects of
tamoxifen treatment by allowing for a sufficient wash-out period. We found that the
circadian genes involved in carbohydrate metabolism were most affected by loss of
Bmal1. The expression of the glycolytic enzymes, Pfkfb1, Pfkfb3, and Hk2 as well as
the PDH phosphatase, Pdp1 were all significantly down-regulated in the
gastrocnemius (Figure 7A). In addition, expression of the adrenergic receptor,
Adrb2, was also significantly decreased. These genes are convincing clock-controlled
candidates in skeletal muscle as they have circadian expression patterns similar to
that of known clock-controlled genes (peak expression during inactive to active
phase transition), and their loss of expression following Bmal1 inactivation is
indicative of direct transcriptional regulation by the clock. By targeting these genes,
the molecular clock mechanism can precisely regulate the timing of carbohydrate
utilization to occur during the active phase. The observation that circadian genes
involved in glucose utilization are diminished in our model is in agreement with the
muscle-specific Bmal1 knockout model generated by Dyar et al. in which they report
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significant decreases in glucose oxidation and insulin stimulated glucose uptake in
their muscle tissues.[68]
Lipid metabolic processes appear to be elevated as the nuclear co-repressor, Nrip1,
involved in repressing β-oxidation was significantly decreased with loss of Bmal1
(approximately 21% decrease, Student’s t test P value = 0.019). Previous studies
have shown that knockout of Nrip1 results in an increase in succinate
dehydrogenase staining of gastrocnemius muscle consistent with a shift to slow
oxidative fiber types.[140] Interestingly, the fatty-acid transporter, Fabp3, and the
β-oxidation genes, Hadha and Hadhb, were significantly elevated in the iMSBmal1−/− gastrocnemius tissues (Figure 7B). Two circadian genes involved in
triacylglycerol elongation, Pnpla3 and Elovl5, were also increased in the iMSBmal1−/−. Altogether, we report significant expression changes in circadian genes
that are key regulators of metabolism in skeletal muscle. We think that the gene
changes observed in iMS-Bmal1−/− are either directly or indirectly regulated
downstream of BMAL1/molecular clock in skeletal muscle and not due to changes in
external cues as circadian activity patterns in iMS-Bmal1−/− are indistinguishable
from vehicle-treated controls. The observation that circadian genes involved in
carbohydrate and lipid metabolism are disrupted in iMS-Bmal1−/− highlights a
fundamental importance of the intrinsic molecular clock in temporal regulation
substrate utilization and storage in skeletal muscle in the absence of external cues.
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2.3.3.1 iMS-Bmal1−/− gene expression changes reveal a fast to slow fiber-type shift
Skeletal muscle is comprised of different fiber types that are differentiated based on
contractile function as well as predominant substrate utilization.[199-202] For
example, fast-type skeletal muscle s (type IIX/IIB) primarily rely on ATP generated
from anaerobic metabolism (glycolysis/lactic-acid fermentation) to provide quick
energy sources required for short bursts of activity, while slow-type skeletal
muscles and fast-type IIA muscles rely on oxidative metabolism to promote a more
sustained and less fatigable bout of contractions. We analyzed changes in gene
expression related to fiber type following Bmal1 ablation in adult skeletal muscle
and included both circadian and non-circadian transcripts. We identified a selective
increase in slow-type sarcomeric genes in the gastrocnemius muscles with a limited
effect on fast-type sarcomeric genes (Figure 8A, B). We chose the list of ‘slow’ and
‘fast’ sarcomeric genes, because these have been shown to be significantly enriched
in either slow-soleus or fast-EDL myofiber preparations.[203] Additionally, calcium
handling genes and nuclear receptors common in slow-fiber muscles (for example,
Casq2, Atp2a2, Ankrd2, Csrp3.) were significantly increased in iMS-Bmal1−/− (Table
1). Similar to the changes observed for the circadian metabolic genes, we see that
non-circadian metabolic genes involved in carbohydrate metabolism are
significantly decreased, while genes involved in lipid metabolism are increased
(Tables 2 and 3). This switch from a fast to a slow fiber-type mRNA profile is in
agreement with the observed metabolic changes as slow fiber-type muscles rely
more heavily on oxidative metabolism compared to fast-type skeletal muscle.
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Table 1 Fiber-type speci�ic gene expression changes in iMS-Bmal1-/Gene Fast or
Gene
ΔExpression
Student’s
symbol slow
description
(tam/veh)
T-test
Atp2a1
Fast
Calcium handling
0.99
ns
Slow Calcium handling
Atp2a2
ns
1.06
Fast
Calm3
Calcium handling
***
0.84
Casq1
Fast
Calcium handling
1.00
ns
Casq2
Slow Calcium handling
2.89
***
Itpr1
Fast
Calcium handling
1.05
ns
Fast
Pvalb
Calcium handling
ns
1.02
Slow
Ankrd2
Nuclear receptor
***
1.66
Csrp3
Slow
Nuclear receptor
2.13
**
Slow
Fhl1
Nuclear receptor
1.28
**
Nfatc2
Slow
Nuclear receptor
0.88
ns
Pdim1
Slow
Nuclear receptor
1.51
***
Slow
Ppara
Nuclear receptor
*
1.23
Ppargc1 Fast
Nuclear receptor
*
0.83
Fast
Sos2
Nuclear receptor
***
0.84
Average gene expression changes of calcium handling and nuclear
receptor genes in iMS-Bmal1-/-. ns, non-signi�icant; * ≤ 0.01; *** ≤ 0.001.
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Table 2 Metabolic genes upregulated in iMS-Bmal1-/Gene symbol
Agpat3
Acadm
Acot7
Acot9
Acsl1
Cd36
Cox5a
Cox6a1
Cpt2
Fabp1
Fabp5
Fads2
Ldhb
Ndufa8
Ndu�b8
Plin5
Sdhc
Sdhd
Uqcr10

Gene function ΔExpression (tam/veh)
Lipogenesis
1.59
Lipolysis
1.31
Lipolysis
1.18
Lipolysis
1.44
Lipolysis
1.24
Lipid transport
1.18
Electron transport chain
1.24
Electron transport chain
1.30
Lipolysis
1.11
Lipid transport
1.28
Lipid transport
1.29
Lipogenesis
1.29
Lactate metabolism
1.33
Electron transport chain
1.24
Electron transport chain
1.18
Lipogenesis
1.41
Electron transport chain
1.18
Electron transport chain
1.21
Electron transport chain
1.14

Student’s
T-test
***
***
***
**
**
**
***
*
*
*
**
*
***
***
**
***
***
**
**

Average gene expression changes of metabolic genes that are signi�icantly
upregulated in iMS-Bmal1-/- skeletal muscle. *P≤0.05; **P≤0.01;***P≤0.001.
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Table 3 Metabolic genes downregulated in iMS-Bmal1-/ΔExpression
Gene
Gene
(tam/veh)
symbol
function
Agl
Glycogenolysis
0.83
Glucose uptake
0.84
Akt1
Glucose uptake
0.86
Il15
0.79
Pak1
Glucose uptake
0.81
P�km
Glycolysis
Pgm2
Glycogenolysis
0.87
Glycogenolysis
0.81
Phka1
Glucose uptake
0.85
Prkab2
0.83
Glucose uptake
Prkag2
0.71
Glucose uptake
Prkag3
0.86
Rab10
Glucose uptake
0.35
Slc2a3
Glucose uptake

Student’s
T-test
***
**
*
*
***
***
**
*
***
**
**
***

Average gene expression changes of metabolic genes that are signi�icantly
downregulated in iMS-Bmal1-/- skeletal muscle. *P≤0.05; **P≤0.01;***P≤0.001.
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2.3.4 Global Analysis of iMS-Bmal1-/- transcriptome
The ablation of Bmal1 in the iMS-Bmal1-/- skeletal muscle resulted in the large-scale
disruption of circadian gene expression patterns well beyond that of the core-clock
genes. The disruption in circadian rhythmicity is visually apparent in the heat-maps
of the circadian genes in the iMS-Bmal1+/+ compared to iMS-Bmal1-/- (Figure 9).
These maps were generated by plotting the temporal expression patterns of the
circadian genes in order of their acrophase. Due to the limited time-points within
our transcriptome, we were unable to use JTK_CYCLE to statistically identify which
genes were circadian or not in the iMS-Bmal1-/-. By analyzing the differential
expression of the circadian genes, we observed approximately 297 and 205 genes
either significantly up or down-regulated in iMS-Bmal1-/-, respectively. Phase
analysis of these genes revealed a temporal component to the genes that were either
up or down-regulated. The majority of genes that were down-regulated in iMSBmal1-/- had a phase of gene expression in wild-type muscle around the transition
from the inactive to active-phase (Figure 10). Inversely, the majority of genes that
are up-regulated had a phase of gene expression around the transition from the
active to inactive-phase. This unique pattern remains consistent when observing
the core-clock gene changes in iMS-Bmal1-/- as genes that are known BMAL1:CLOCK
targets with phases around CT 12.0 are significantly decreased (e.g. Dbp, Per2, Reverb, Rora, etc.) (Appendix File 7). Interestingly, three core-clock genes (Clock, Nfil3,
and Npas2) are up-regulated in the iMS-Bmal1-/- tissue and reach peak expression in
an antiphasic manner to that of the other core-clock genes (~CT 24.0) (Figure 11).
Analysis of the gene expression profile in the iMS-Bmal1-/- shows that Clock, Nfil3,
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Figure 9. Heat-maps of the muscle circadian transcriptome genes in
iMS-Bmal1+/+ (left) and iMS-Bmal1-/- (right) muscle tissue. Probsets are
plotted by phase with high expression in yellow and low expression in blue
over the circadian time-course from CT 18.0 to 36.0.
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Figure 10. Diagram of the differentially expressed genes in iMS-Bmal1-/muscle tissue plotted according to the acrophrase of gene expression. Red
bars indicate the total number of genes that were signi�icantly up-regulated at
least 20%, while black bars indicate the total number of genes that were
signi�icantly down-regulated 20% in the iMS-Bmal1-/- time-course microarray data set compared to iMS-Bmal1+/+.
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and Npas2 are not only up-regulated at all time-points, but also seem to flat-line
which may suggest a common upstream transcriptional regulator. Interestingly, all
three of these genes contain RORE’s within their promoter regions and have been
shown to be target for repression by REV-ERBα during the active phase. The
expression of Rev-erbα is markedly decreased in the iMS-Bmal1-/- as this gene is a
direct BMAL1:CLOCK target. The loss of Rev-erbα expression in other genetic
models have been shown to result in a de-repression of REV-ERBα target genes
resulting in an increase in their expression similar to the up-regulated circadian
genes in our analysis.[64, 204] The loss of Rev-erbα has also been associated with
an increase in an oxidative phenotype.[204] From these observations we propose a
model in which both limbs of the core-molecular-clock, BMAL1:CLOCK and REVERBα, function to rhythmically activate or repress gene expression during the active
period (Figure 12). Further analysis involving a time-course ChIP-seq analysis for
both BMAL1 and REV-ERBα would help to further elucidate potential mechanisms.
2.4 Conclusion
Here, we report that the intrinsic molecular-clock regulates the timing of genes
involved in substrate catabolic and anabolic processes in skeletal muscle. We have
identified the mid-inactive period as the time of peak expression of genes involved
in fatty-acid breakdown, possibly serving as the main energy source to skeletal
muscle during the overnight fasting period. The temporal expression pattern of
genes that regulate glycolysis and glycolytic flux into the TCA’s cycle suggests a shift
in substrate utilization during the early active period from lipids to carbohydrates,
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Figure 12. Proposed model demonstrating how BMAL1:CLOCK promote the
expression of glycolytic genes during the active phase while REV-ERBs
repress lipogenic genes during the active phase. Loss of BMAL1 expression
results in a decrease in the circadian and overall expression of glycolytic
genes and REV-ERBs resulting in a de-repression of REV-ERB target genes.
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which has previously been documented in other muscle-specific Bmal1 knockout
models.[68] Genes involved in glucose and lipid storage were observed as reaching
peak expression toward the end of the active phase, where we predict excess energy
is stored for usage during the post-absorptive phase. Expression analysis of timecourse data from iMS-Bmal1−/− skeletal muscle revealed the differential expression
of a number of key circadian metabolic genes in the absence of BMAL1. These
findings suggest that the temporal regulation and circadian rhythmicity of these
genes is directly downstream of the intrinsic skeletal muscle molecular-clock
mechanism. We observe a gene expression profile that is indicative of a glycolytic to
oxidative fiber type shift with loss of Bmal1 in adult muscle tissue. These findings
suggest a potential unidentified role of Bmal1 in the maintenance of fast-type
muscle fibers, possibly via direct transcriptional regulation of glucose handling. It is
widely reported that aging is associated with a selective loss of fast-type skeletal
muscle fibers.[205, 206] In addition, aging is also associated with decreases in the
robustness of the molecular clock.[69, 207] These observations raise the possibility
that fast to slow fiber-type shifts may be a result of dampening of the molecular
clock with age. Lastly, our observations from the temporal phase analysis of the
differentially expressed genes has led us to propose a potential mechanism in which
the molecular-clock both activates and represses gene transcription during the
active phase.
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3 Chapter 3: The molecular-clock and MYOD1 promote the circadian expression of
Titin-cap in skeletal muscle
3.1 Introduction
The molecular-clock is an endogenous, transcriptional-translational feedback
mechanism responsible for the circadian regulation of genes and physiological
processes in peripheral tissues.[4-6] In addition to its vital role in regulating
metabolism, there is a growing recognition that the molecular-clock plays
fundamental roles in both the development and maintenance of skeletal muscle.[66,
84] Bmal1 and CLOCK are PAS-bHLH transcription factors that form the positivelimb of the molecular-clock.[45] Bmal1, in particular, has been shown to promote
myogenesis via the activation of the myogenic regulatory factors (MyoD1, Myf5,
Myogenin) and the Wnt-signaling cascade.[84] Bmal1 is also involved in the
regeneration of skeletal muscle, the process in which resident satellite cells are
activated and fuse to form new muscle.[83] The myogenic and regenerative
functions of Bmal1 are even more so apparent in the skeletal muscle phenotypes
present in Bmal1-/- and include: Significant decreases in specific-force generation,
disruptions in myofibrillar organization, and decreases in total muscle-mass.[66]
Although we did not observe significant decreases in muscle mass, our lab has
observed similar decreases in specific force in an inducible skeletal muscle specific
model suggesting that this effect is intrinsic to the molecular-clock in adult muscle
(Manuscript Submitted JAP).
To understand how the molecular-clock regulates skeletal muscle physiology
investigators have sought to identify CCGs and to understand the mechanisms in

56

which the clock regulates these genes.[208-211] It is currently unknown how the
molecular-clock targets genes in a tissue specific fashion, although some have
proposed this may occur through interactions between the clock machinery and
resident tissue specific factors.[49, 212] The validation of the myogenic regulatory
factor, MyoD1, as a direct target of the molecular-clock has raised the possibility that
oscillations in this protein could be responsible for rhythmic regulation of musclespecific processes. Myod1, along with the other myogenic regulatory factors Myf6,
Myogenin, and Mrf5 are considered ‘master-regulators’ of the transcriptional
program that promotes skeletal muscle differentiation.[213] These proteins, like
Bmal1 and Clock, are bHLH factors that homo- and heterodimerize with themselves
and other transcription factors and bind to canonical E-box elements (CANNTG) to
promote myogenic gene expression.[214, 215] The activity of MYOD1 to promote
gene expression depends on the DNA-binding stability, intramolecular interactions
that influence MYOD1’s conformation-state, and the presence/absence of co-factors
that recruit additional transcriptional machinery and/or alter chromatin
structure.[216-219]
In the present study, we test whether the molecular-clock and MYOD1 work
together to promote the circadian expression of the muscle-specific gene T-cap. We
chose T-cap as a model gene to test this potential transcriptional mechanism in
skeletal muscle as this gene has previously been identified as BMAL1:CLOCK target
gene in heart-tissue, and is activated by MYOD1 during myogenesis.[96, 99] Using a
bioinformatics approach we first identify T-cap as a circadian transcript that is
significantly down-regulated in our iMS-Bmal1-/- model. We demonstrate in C2C12
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muscle-cells that the proximal promoter of T-cap is directly targeted by both the
molecular-clock and MYOD1. Our study provides evidence of a novel mechanism in
which that molecular-clock factors, BMAL1:CLOCK, work cooperatively with the
myogenic regulatory factor MYOD1 to promote the circadian expression of T-cap.
3.2 Materials and Methods
3.2.1 Generation of iMS-Bmal1+/+ and iMS-Bmal1-/- mice and protein isolation
Thirty-two adult iMS-Bmal1flox/flox mice (12-14 weeks old) were treated with Vehicle
or Tamoxifen as described in section 2.4.3. Five weeks post injection 17 tamoxifen
and 15 vehicle treated mice were entrained to a 12-h LD cycle for 14 days, and had
ad libitum access to food and water. Following the entrainment period, the mice
were euthanized at either CT2 or CT14 and gastrocnemius tissues from both hind
limbs were flash frozen in liquid nitrogen and stored at -80°C. Tissues were weighed
and homogenized mechanically in RIPA buffer (40 w/v) containing inhibitors
(Complete Mini EDTA-Free Protease Inhibitor from Sigma Aldrich, 1% NaF, and 1%
Na-Orthovandate) on ice. Cell-debris were pelleted at 10,000g for 10 minutes at 4°C
and supernatants were quantified for protein concentration via Lowry method.
3.2.2 Western-blot
Whole cell lysates were prepared from gastrocnemius tissue from iMS-Bmal1-/- and
iMS-Bmal1+/+, and liver lysates were prepared from wild-type mice as a negative
control. Immunoblotting were carried out with routine protocols. Briefly, proteins
were denatured for 5 minutes at 95°C in 5x reducing buffer. Approximately 40μg of
total protein were added to each well of a SDS-PAGE gel containing a 4% stacking
and 12% running gel, and proteins were separated by electrical current. The
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proteins were then transferred to a PVDF membrane via a semi-dry transfer
apparatus (BioRad). The membranes were placed in blocking solution (Odyssey)
for 1 hr. The blots were then cut at approximately 35Kda, and the bottom portion
was incubated with a monoclonal Anti-T-CAP primary antibody produced in mouse
at a 1:200 dilution (Sigma-Aldrich, WH0008557M1) while the top portion was
incubated with a polyclonal Anti-γ-tubulin primary antibody produced in mouse at a
1:5000 dilution (Sigma-Aldrich). The primary antibodies were detected by goatanti-mouse Alexa Fluor® 647 secondary (Abcam150115) and visualized using the
Odyssey system (Li-Cor, Lincoln, NE, USA).
3.2.3 RNA isolation and Real-time PCR
RNA was isolated from gastrocnemius tissue via TRIzol method and cDNAs
prepared as described in section 2.2.4. (RNA samples prepared in the previous study
were used for this study). Real-time quantitative PCR was performed using TaqMan
(Applied Biosystems, Waltham, MA, USA) assays to determine the gene expression
of T-cap (MM00495557_g1) and the ΔΔCT method was used for the quantification of
the real-time PCR data. The gene Rpl26 was quantified for normalization as this
gene is highly expressed in skeletal muscle and does not oscillate over time of day.
3.2.4 Plasmids
The T-cap luciferase promoter-reporter construct was a gift from Dr. Davie from
Southern Illinois University School of Medicine and contains a 421 base pair
promoter fragment that spans from -421 to +1 of the translational start site.[99] The
Bmal1 mutant vector BMAL1-R91A was a gift from Dr. Takahashi from the
University of Texas Southwestern. The MYOD1-3Δ56 construct was a gift from Dr.
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Rudnicki at the Ottawa Hospital Research Institute. The control plasmid we used as
an empty vector control was the PGEM vector from Promega. The wild-type
expression vectors used in this study include: MYOD1, BMAL1, CLOCK. In addition
to the T-cap reporter, we also used a Bmal1:luciferase reporter that contains the
Bmal1 promoter cloned into the pGL3 reporter vector.
3.2.5 Site-directed mutagenesis
The QuikChange Site-Directed Mutagenesis Kit was used to mutate the tandem Ebox element in the proximal promoter region of the T-cap:Luciferase vector
according to the manufacturers instructions. The forward and reverse primer
sequences are as follows: Reverse-5'-ggcacatgggcagcctgcacccaccttggcactgtc-3',
Forward-5’-gacagtgccaaggtgggtgcaggctgcccatgtgcc-3'. The mutated T-cap sequence
can be found in Appendix File 3.
3.2.6 Dual-Luciferase Assay
The Dual-luciferase assay is commonly used to quantify the activity of the reporter
(Firefly luciferase), and the co-transfection control (Renilla luciferase). The
presence of this internal control serves as a baseline response, so variability due to
pipetting error, cell lysis, or transfection efficiency are greatly diminished. To study
the transactivation of T-cap:luciferase we performed transient co-transfections of
the T-cap:luciferase promoter-reporter construct with expression plasmids in
C2C12 myoblasts. For each well of a 24-well tissue culture plate we mixed 50ng Tcap:luciferase reporter, 5ng pRL reporter (Renilla), and 300ng each of the
expression vectors (MYOD1, BMAL1, CLOCK, BMAL1-R91A, MYOD-3Δ56) in
approximately 0.5mL of DMEM (no serum) and Xtreme-gene9 transfection reagent
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5ul/1,000ng DNA. The DNA/transfection mix was then mixed with free-floating
myoblasts (50,000/well) and plated with fresh GM (DMEM, 10%FBS, 1%Pen/Strep).
Each transfection was performed in quadruplicate. GM was changed the following
day and DM (DMEM, 2%HS, 1%Pen/Strep) was added at day 3. The cells were
differentiated for 48-h in DM to form myotubes. The cells were lysed with 5x
Passive Lysis Buffer (Promega) for 15 minutes shaking at room-temperature and
cell extracts were then measured for Luciferase and Renilla activity according to the
manufacturer’s instructions (Promega).
3.2.7 Lumicycle
Co-transfections were performed as described in the previous sections in C2C12
myoblasts. Approximately 150ng of T-cap:luciferase or Bmal1:luciferase reporter
vectors were transfected per 35mm dish. Expression plasmids or negative controls
(PGEM) were co-transfected with approximately 500ng per 35mm dish. C2C12
myoblasts were plated with the transfection/DNA mix at 300,000 cells per 35mm
dish in fresh GM. After 48-h the GM was switched to DM, and the cells were
differentiated for 5-full days (DM refreshed every other day). After differentiation,
the myotubes were synchronized with dexamethasone (1μΜ) for 90 minutes, and
then washed with PBS twice and 1.5mL of Recording buffer was added (DMEMPhenol Red free, 10mM HEPES, luciferin 0.1mΜ, 1%Pen/Strep, 2% Horse Serum,
sodium bicarbonate 350mg/L). Cells were then airtight sealed and placed in the
lumicycle apparatus. A 32-well turn-table is fully automated so that the
photomultiplier tubes captured and recorded the number of photons given off by
each culture dish every five minutes. The luminometry data was stored as photon
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counts/second on a computer using the lumicycle software by Actimetrix.
JTK_CYCLE analysis was performed on the lumicycle data as follows: The first 1.5
days of recording was excluded to allow the cells to equilibrate fully after changes in
temperature and media that occur during setup. We condensed the data for ease of
handling and improved computational efficiency by binning data-points from every
5-minutes to two hour intervals. The relative phase is a measurement of the initial
peak following the beginning of the analysis (CT 1.5).
3.2.8 Chromatin Immunoprecipitation
To determine binding of BMAL1 and MYOD1 on the T-cap promoter regions we
performed ChIP analysis with primers that scan the tandem-E-Box element and
primers for the most proximal E-Box element on the T-cap promoter. We
performed ChIP analysis as described in Andrews et al. 2010.[66] Briefly, C2C12
myotubes were synchronized with 1μM dexamethasone for 90 minutes then
crosslinked with 1% formaldehyde solution at room temperature for 11 minutes.
Following sonication, the fragmented chromatin was pre-cleared with protein-A/G
beads and then immunoprecipitated with antibodies against IgG, BMAL1 (Abcam),
and MYOD1 (Santa-Cruz). Antibodies were then pulled down with protein-A/G
beads, washed, and the DNA was eluted using the QIAquick purification kit (Qiagen).
Quantitative Real-Time PCR (SyberGreen method) was performed using DNA from
the input reaction, serum, and pull-downs from IgG, MYOD1, and BMAL1. Primers
for the T-cap promoter are as follows: Tandem-E-Box element Forward:5’AGCAGAGGAAGACAGTGCCAA-3’, Reverse:5’-AAGATGCTCTGTTGGGGACCTG-3’;
proximal E-Box element Forward:5’-CAGGTCCCAACAGAGCATCTT-3’, Reverse:5’-
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GGGGCTATTTTCAGCCCCTCTG-3’. Primers for the Myogenin promoter were used as
a positive control for MYOD1 binding, and primers for the Period-2 promoter were
used as a positive control for BMAL1 binding. To visualize the qRT-PCR reaction,
the samples were run on a 4% stacking, 10% polyacrylamide gel, stained with a
fluorescent DNA stain, and imaged with a Typhoon scanner.
3.2.9 Co-Immunoprecipitation
To determine if BMAL1 and MYOD1 bind in a protein:protein interaction we used
the Nuclear Complex Co-IP kit (Active Motif) according to the manufacturer’s
instructions. To improve specificity and strength of the pull-down we transiently
transfected C2C12 myoblasts with expression vectors for BMAL1-HA
(Hemagglutinin) & MYOD1, or MYOD1-HA & BMAL1. We performed the pull-down
reactions with an anti-HA (Sigma Aldrich) and anti-IgG antibodies. Western-blots
were then performed with antibodies against BMAL1 (for MYOD-HA pull-down) or
MYOD1 (for BMAL1-HA pull-down).

3.3 Results and discussion
3.3.1 Circadian Bioinformatics and Identification of a Candidate Clock-Controlled
Gene: Titin-Cap (Tcap)
The decreases observed in specific-force generation in the skeletal muscle of iMSBmal1-/- mice suggests that the molecular-clock mechanism may be sufficient to
modulate the expression of genes involved in muscle structure and/or function. We
employed a circadian bioinformatics workflow to determine if T-cap displays
characteristics of a clock-controlled gene in skeletal muscle. Figure 13 outlines the
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Bioinformatics Work�low
Circadian Expression in
Gastrocnemius
• JTK_Cycle p-value<0.05
~1,368 genes
Expression Similar to
Known CCGs
• Dbp Spearman’s Rho pvalue<0.05
161 genes

Signi�icant Decrease In
Expression in iMS-Bmal1-/• T-test p-value<0.05
68 genes
Enriched in Skeletal
Muscle
• Bio-GPS
• Fold Change > 3.0
5 genes

Figure 13. Schematic of the bioinformatics work�low to identify skeletal
muscle speci�ic clock-controlled genes.

64

bioinformatics workflow that resulted in the identification of T-cap and four other
genes that adequately fit our criteria as potential skeletal muscle specific CCGs. A
brief description of our analysis is as follows: To identify genes that are direct
targets of BMAL1:CLOCK we chose to focus on circadian genes with similar gene
expression patterns as that of the clock-controlled gene Dbp. To do so we utilized
the Spearman’s Rho rank correlation coefficient test, which is a non-parametric test
commonly used to statistically identify similar patterns. As was established in
chapter 2, the majority of known BMAL1:CLOCK targets displayed decreases in
overall gene expression in the iMS-Bmal1-/- muscle tissue, so we next choose to
focus on genes that are significantly decreased with loss of Bmal1. At this step, 12 of
the 68 genes were known targets of BMAL1:CLOCK, a finding that suggests the
genes within this list are strong CCG candidates. Lastly, we choose to identify the
genes that are highly enriched in skeletal muscle yielding the 5 muscle-specific CCGs
including T-cap. Figure 14 demonstrates the circadian pattern of T-cap mRNA
expression generated from the Hogenesch circadian time-course microarray.
JTK_CYCLE analysis of the T-cap expression profile found the transcript to be highly
statistically circadian (p-value: 0.00031). T-cap is one of the most highly expressed
transcripts in skeletal muscle, and compared to the circadian muscle transcriptome
its expression ranks in the 99th percentile. Real-time PCR was performed in iMSBmal1+/+ and iMS-Bmal1-/- muscle-tissue (gastrocnemius) to further validate the
oscillation of T-cap mRNA that was observed in the Hogenesch time-course
microarray. We observed a circadian gene expression pattern of T-cap with peak
expression occurring at the transition from inactive to active-phases in the iMS-
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Figure 14. Temporal expression pattern of T-cap from the Hogenesch
skeletal muscle circadian transcriptome. The black circles represent the
expression values of T-cap at each circadian time-point. The dotted line is a
6-degree polynomial �itted to the T-cap expression data. Grey bars indicated the active period, and white bars indicate the inactive period. Note that
mice were in constant darkness during the time-course collection.
JTK_CYCLE p-value 0.00031, period 24h, phase CT12.
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Bmal1+/+ muscle (Figure 15).

The temporal expression pattern of T-cap is

indicative of a BMAL1:CLOCK down-stream target gene as direct CCGs typically
reach peak expression in an anti-phasic manner to that of Bmal1. These findings are
in agreement with that of T-cap’s circadian expression profile that has been
documented in heart-tissue. [96] As expected, the circadian expression pattern of Tcap was completely abolished in the iMS-Bmal1-/- muscle tissue. Additionally, the
overall gene expression of T-cap was reduced on average ~66%. Since the activity
pattern of iMS-Bmal1-/- mice is indistinguishable from that of the controls, we argue
that T-cap expression is regulated downstream of the molecular-clock, and that the
observed expression changes are caused by the loss of Bmal1 in skeletal muscle.
3.3.2 T-cap is circadian in wild-type skeletal muscle
Although circadian transcriptome analyses are very accurate at identifying
oscillatory transcripts, it is becoming increasingly evident in the field of circadian
rhythms that protein expression does not always mirror that of the transcript so we
quantified T-CAP protein expression over time. Western-blot analysis of T-CAP
from wild-type skeletal muscle (gastrocnemius) demonstrates the circadian
oscillation of T-CAP protein with peak expression occurring during the early activephase (Figure 16). The finding that T-CAP oscillates at the protein level suggests
that the relative T-CAP protein content, at any given circadian time, may be directly
proportional to the relative amount of T-cap transcript levels. T-CAP protein levels
seem to follow the mRNA expression pattern with a slight-lag, which is typical of a
circadian gene. These observations do not however discount the possibility that TCAP protein expression may also be temporally modulated by post-translational
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Figure 15. T-cap real-time PCR results of time-course expression values in
the iMS-Bmal1+/+ (black) and iMS-Bmal1−/− (red). Fold difference was
calculated from control, Rpl-26 Real-Time PCR for each time-point. Grey bars
indicated the active period, and white bars indicate the inactive period. Mice
were in constant darkness during the time-course collection.
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Figure 16. Representative western-blot (A) of T-CAP and γ-TUBULIN in
wild-type gastrocnemius tissue from CT 18.0 to 46.0. Quanti�ication (B) of
the T-CAP to γ-TUBULIN loading control in the skeletal muscle tissue.
JTK_CYCLE p-value:0.0089, period 24h, phase CT0. Wild-type liver tissue
was used a negative control for the T-CAP antibody.
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mechanisms. T-CAP is among a handful of sarcomeric proteins ubiquitinated by the
muscle-specific E3-ubiquitin ligase, MURF1 (Trim63) and is targeted for degradation
by the 26S proteasome.[220] Interestingly, we found that Trim63/Murf1 is circadian
in skeletal muscle (p-value 0.0024), and is expressed in an anti-phasic manner to
that of T-cap (phase CT23.0) (Apendix File 8). We predict Murf1 levels to be
highest at the end of the active-phase. During the inactive-phase, in addition to
lower transcript levels caused by a decrease in BMAL1:CLOCK transactivation, the
skeletal muscle may also more readily target T-CAP for degradation by MURF1 to
keep T-CAP protein levels low during this time period. Additional experimentation
is required to determine whether T-CAP is modified post-translationally, or
degraded in a circadian manner as these experiments are outside the scope of this
dissertation.

3.3.3 T-cap’s expression and circadian oscillation are dampened in iMS-Bmal1-/muscle tissue
The iMS-Bmal1-/- transcriptome analysis (section 2.3.4) revealed large-scale
disruptions of the circadian transcripts. BMAL1, together with CLOCK/NPAS2,
function as the positive limb of the molecular-clock.[7] To determine if T-CAP
protein was also reduced in the iMS-Bmal1-/-, we compared protein expression via
western-blot of muscle extracts from iMS-Bmal1+/+ and iMS-Bmal1-/- muscle tissue at
CT2 and CT14 (n=8 per treatment and time-point). These times were chosen based
on the temporal gene expression pattern of T-cap as CT2 represents 2 hours into the
inactive-phase when mRNA expression is dampening, while CT14 is 2 hours into the

70

active-phase when mRNA expression is highest. Overall T-CAP protein was greatly
diminished in iMS-Bmal1-/- muscle tissue as to be expected from the real-time PCR
results (Figure 17). These results further argue that T-CAP protein expression is
regulated by the relative amounts of T-cap mRNA present within the cell.

3.3.3.1 T-cap:luciferase oscillates in an anti-phasic manner to Bmal1:luciferase in
vitro
It is widely known that the timing of the molecular-clock can be influenced by
numerous environmental time-cues (Zietgeibers).[49] For instance, the skeletal
muscle clock phase-shifts in response to external time-cues, such as time of
exercise.[73] External environmental stimuli and downstream cell-signaling
cascades can also influence gene expression in the absence of the molecular-clock
mechanism. In this manner it is possible for genes to oscillate in a circadian manner
without being directly regulated by the molecular clock. The observation that T-cap
mRNA and protein oscillates in a circadian manner in skeletal muscle suggests that
it is regulated downstream of the endogenous molecular clock, but the in vivo
setting in which these assays were performed raises the possibilities of confounding
factors such as eating or activity patterns (both highly circadian in nature)
potentially influencing the T-cap circadian oscillation. In order to account for the
presence of such confounding factors we decided to assay the circadian rhythmicity
of T-cap in an in vitro environment null of external time-cues. For our analysis we
choose to record T-cap promoter:reporter luciferase bioluminescence in
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Figure 17. Representative western-blot (A) of T-CAP and γ-TUBULIN in
wild-type gastrocnemius tissue from iMS-Bmal1+/+ and iMS-Bmal1-/- at CT
2.0 and 14.0. Quanti�ication (B) of the T-CAP to γ-TUBULIN loading control.
Wild-type liver tissue was used a negative control for the T-CAP antibody.
***P ≤ 0.001.
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synchronized C2C12 myotubes over multiple circadian cycles.

The T-cap

promoter:reporter construct we utilized in our study consists of a 421 base-pair
proximal-promoter region cloned upstream of Firefly luciferase gene (Appendix
File 10).

To detect T-cap biolumenesnce we used a Lumicycle incubator

(Actimetrix), as this is a powerful tool for measuring multiple parameters of
circadian rhythmicity (period length, amplitude, acrophase), because it allows for
the recording of bioluminescence for successive days with high temporal
resolution.[221] We observed a robust circadian oscillation of T-cap:luciferase
activity with an approximate 22 to 24 hour period length in C2C12 myotubes
(Figure 18). Furthermore, the T-cap:luciferase circadian pattern is antiphasic to
that of Bmal1:luciferase activity in C2C12 myotubes synchronized at the same time.
The observation that the T-cap:Luciferase reporter displays a circadian oscillation in
C2C12 myotubes indicates that the T-cap promoter contains the essential elements
necessary for downstream regulation by the endogenous molecular-clock in the
absence of external time-cues. The antiphasic manner in which T-cap:luciferase is
expressed in vitro, in comparison to Bmal1:luciferase, is very typical of a CCG and
further supports the direct regulation of T-cap by the BMAL1:CLOCK transcription
factors.

3.3.4 BMAL1:CLOCK transactivate T-cap:luciferase activity
The significant decreases in T-cap expression in iMS-Bmal1-/- muscle tissue argues
that T-cap is transcriptionally regulated down-stream of the clock, but does not
discount the possibility that T-cap mRNA and protein are decreased due to an
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Figure 18. Representative graph of baseline subtracted Bmal1:luciferase
(black circles) and T-cap:luciferase (red circles) over days in culture. Error
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alternative mechanism. For instance, T-cap expression could dampen in response to
Bmal1 knockout via alternative mechanisms such as enhanced mRNA instability or
protein turnover since we have observed the circadian oscillation of a number of
genes that encode muscle specific E3-ubiquitin ligases. Therefore, we sought to
determine if BMAL1:CLOCK transcriptionally activate T-cap expression in skeletal
muscle by performing a series of dual-reporter assays (Dual-Luciferase Reporter
Assay System, Promega) in C2C12 muscle cells co-transfected with T-cap:Luciferase
(reporter), Renilla luciferase (control-reporter), and expression plasmids for BMAL1
and CLOCK. The dual-reporter system is commonly used to accurately quantify
transactivation of promoter-reporter constructs. Overexpression of the molecularclock factors, BMAL1:CLOCK, appeared to drive a slight increase T-cap:Luciferase
activity (~2-fold) in C2C12 myotubes (Figure 19). A possible explanation for why
BMAL1:CLOCK do not drive a robust increase in T-cap:Luciferase activity, is that
additional factor(s) are required to promote T-cap expression in skeletal muscle .
Interestingly, we observed no apparent increase in T-cap:Luciferase activity when
we over-expressed a mutant form of BMAL1 that contains an A91G point mutation
rendering the protein incapable of binding DNA (Figure 19).

3.3.5 MYOD1 works in a synergistic fashion with BMAL1:CLOCK to drive T-cap
expression
Zhang et al. have previously shown that the T-cap promoter is responsive to the
muscle specific transcription factor MYOD1 in NIH-3T3 fibroblasts.[99] Additionally,
this group suggests that MYOD1 plays a role in promoting T-cap expression during
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Figure 19. Dual-luciferase results for T-cap:luciferase reporter co-transfected with expression plasmids for BMAL1 and CLOCK, or BMAL1-R91A mutant
and CLOCK normalized to the empty vector control. n=3/sample.
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development as they demonstrated MYOD1 binding to the T-cap promoter during
embryogenesis.[99] We observed a 5-fold induction of T-cap:luciferase activity with
transient transfection of MYOD1 in C2C12 myotubes compared to the empty vector
pGL3 control (Figure 20). The MYOD1 protein contains multiple domains that
function to promote gene expression in several ways.[222] MYOD1 contains a
transactivting domain (TAD) involved in protein:protein interactions that recruit
transcriptional machinery and other transcription factors to myogenic promoter
regions.[223, 224] MYOD1 also contains two chromatin remodeling domains that
recruit histone acetylases to promote euchromatin formation to allow additional
transcription factors to more readily access the DNA.[225] To determine the
functional importance of MYOD1’s TAD in regulating T-cap expression we repeated
the dual-luciferase assay with a MYOD1 mutant expression plasmid, Myod1-3Δ56,
that lacks the TAD.[224] We observed no enhancement of T-cap:luciferase activity
with overexpression of Myod1-3Δ56, and luciferase activity appeared to be
dampened below that of the control levels (Figure 20). These results suggest that
the MYOD1 mutant may be acting in a dominate-negative fashion, where it may be
out-competing endogenous MYOD1 for the T-cap promoter.
To test whether MYOD1 is required for BMAL1:CLOCK mediated transactivation of
T-cap we measured T-cap:luciferase activity in C2C12 myotubes co-transfected with
MYOD1 and BMAL1:CLOCK. Interestingly, over-expression of MYOD1 with
BMAL1:CLOCK resulted in a ~20 fold induction of T-cap:luciferase activity (Figure
21), which is approximately 10 fold higher than BMAL1:CLOCK over-expression
alone. These data indicate that MYOD1 and the molecular-clock factors work in a
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synergistic fashion to promote T-cap expression, as the induction of T-cap:luciferase
activity is much greater than one would expect if the interaction was additive. The
ability of BMAL1:CLOCK to transactivate T-cap was abolished with over-expression
of the mutant form of MYOD1 (Figure 21), suggesting that MYOD1 function is
required for the molecular-clock to promote T-cap expression in skeletal muscle . A
number of possibilities exist that would help explain as to why T-cap oscillates in
heart tissue in the absence of MYOD1. It is possible that BMAL1:CLOCK interact
with a heart-specific co-factor that is required for the expression of T-cap in the
heart such as the heart-specific bHLH transcription factors Hand1 and Hand2.
Another possibility is that skeletal muscle possesses a negative-regulator that
suppresses the ability of BMAL1:CLOCK to transactivate T-cap expression in the
absence of MYOD1.

3.3.5.1 MYOD1 enhances the amplitude of the T-cap:luciferase oscillation
To further explore the role MYOD1 plays in regulating the circadian expression of Tcap we assayed T-cap activity (lumicycle) for approximately 4.5 days while overexpressing wild-type or mutant MYOD1. In addition to enhancing T-cap expression,
MYOD1 over-expression promoted a ~10-fold increase in the amplitude of the Tcap:Luciferase rhythm (Figure 22A). The increases in the amplitude of the rhythm
seemed to have little effect on period length or phase. We observed a marked
decrease in the amplitude of the T-cap:Luciferase rhythm with over-expression of
MYOD1-3Δ56(Figure 22B).

Interestingly, the circadian pattern of the T-cap-
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Figure 22. Representative graph of baseline subtracted T-cap:luciferase
reporter values with co-transfection of MYOD1 (A) and MYOD1-3Δ56 (B).
Error bars denote SEM. Red circles indicate the co-transfected values. The
black circles represents T-cap:luciferase values with no co-transfection.
T-cap:luciferase-JTK_CYCLE: p-value 2.07E-11, period 20, relative phase CT
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relative phase CT 2.0.
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luciferase rhythm appeared to be unaltered with over-expression of the MYOD13Δ56 construct, suggesting that MYOD1 may only regulate the transactivation and
amplitude of the T-cap oscillation while having minimal control on the actually
timing of the rhythm. MYOD1 protein expression peaks in the mid-inactive phase
(~CT 6.0), which is also approximately when BMAL1:CLOCK reaches peak
transcriptional activity.[66] These data suggest that BMAL1:CLOCK and MYOD1 may
transactivate genes during the inactive-phase to promote CCG expression to peak
during the early active-phase. Further temporal binding and transcriptional studies
are required to determine if MYOD1 and BMAL1:CLOCK target the same promoter
regions, and whether they bind at similar times through the day.

3.3.6 BMAL1 and MYOD1 bind to the tandem E-box element in the T-cap promoter
Two E-box elements have previously been identified within the T-cap promoter.[99]
Zhang et al. demonstrated MYOD1 binding on the proximal E-box element during
embryogenesis, while Podobed et al. have shown BMAL1 binding to the distal
tandem E-box element in heart tissue.[96] We performed a ChIP assay to determine
if both BMAL1 and MYOD1 bind to the T-cap promoter in C2C12 myotubes.
Compared to IgG control, we observed an 8 and 3-fold enrichment of BMAL1 and
MYOD1 binding on the distal portion of the T-cap promoter where the tandem E-box
element is located, respectively (Figure 23A, B). While we did not detect any
BMAL1 binding on the proximal portion of the T-cap promoter, we did see a small
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amount of MYOD1 binding (data not shown). As positive controls for our antibodies
we observed binding of MYOD1 on the Myogenin promoter, and BMAL1 binding on
the Period-2 promoter (Figure 23C, D).
3.3.6.1 The tandem E-box in the T-cap promoter is required for BMAL1:CLOCK and
MYOD1 transactivation and circadian expression pattern
Due to the observed binding of both BMAL1 and MYOD1 within the region of distal
promoter region containing the tandem E-box element, we aimed to identify
whether the tandem E-box element is required for BMAL1:CLOCK/MYOD1 mediated
transactivation and/or the circadian rhythmicity of T-cap. To this end, we mutated
the 5’-E-box of the tandem E-Box element of the T-cap:luciferase reporter by sitedirected mutagenesis (CAGCAG to GTGCAG), and performed a series of dualreporter and lumicycle assays. The mutated T-cap reporter (denoted as T-mut) was
unresponsive to transactivation by over-expression of BMAL1:CLOCK, MYOD1, and
BMAL1:CLOCK+MYOD1 compared to empty vector controls (Figure 24). The T-mut
reporter also displayed abnormal temporal expression patterns, and the MYOD1
mediate enhancement of the amplitude observed for the wild-type T-cap:luciferase
reporter was abolished (Figure 25A, B). Along with the ChIP studies, these data
indicate that BMAL1:CLOCK and MYOD1 interact with the tandem E-box element
within the T-cap promoter, and this element is required for the circadian expression
pattern of T-cap.
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Figure 25. Representative graph of baseline subtracted T-cap:luciferase
(black) and Tmut:luciferase (red) reporter values (A). T-mut:luciferase
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86

3.3.7 MYOD1 and BMAL1 do not form a protein:protein interaction in C2C12
myotubes
The synergistic interaction of MYOD1 and BMAL1:CLOCK, and the observed
increases in the circadian amplitude of T-cap:luciferase with overexpression of
MYOD1 suggests the potential for these factors to physically interact. To test this
potential interaction we performed a series of co-immunoprecipitation assays. We
first over-expressed either MYOD1 or BMAL1 fusion proteins contacting a
hemaglutanin tag on their C-terminal end (MYOD1-HA, BMAL1-HA). We then pulled
down these proteins using an antibody against hemaglutanin (IgG was used as the
control pull-down). Western-blotting for either BMAL1 (bound to MYOD1-HA) or
MYOD1 (bound to BMAL1-HA) did not produce sufficient bands, and we therefore
do argue that these factors do not directly dimerize (Figure 26).
3.3.8 Conclusion
Here we report the identification and validation of T-cap as a direct clock-controlled
gene in skeletal muscle. The temporal expression pattern of the T-CAP protein
suggests that it is most-highly expressed during the active phase of the circadian
cycle.

At this time, the potential functional consequences of rhythmic T-CAP

expression are unknown, but the highly conserved E-box elements within its
promoter and the complex nature in which it is transcriptionally regulated suggests
that this is more than a mere vestigial mechanism in skeletal muscle. The novelty of
this study exists not so much in the identification of T-cap as a CCG, but in the
observations that a muscle-specific transcription factor, MYOD1, can work in a
synergistic nature with the molecular-clock to drive the expression of a muscle-
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specific gene. The fact that T-cap is robustly circadian in heart-tissue, which does
not express MYOD1, suggests the existence of an unknown heart-specific
transcription factor. Additional studies are required to fully elucidate the molecular
mechanisms in which these co-factors work together, but it is clear, at-least in our
hands, that MYOD1 and the molecular-clock factors BMAL1:CLOCK do not bind in a
protein:protein interaction.
One possible mechanism in which muscle-specific genes are targeted for circadian
oscillation is that MYOD1 and/or BMAL1:CLOCK work as pioneering factors that
recruit chromatin remodeling enzymes to expose binding elements within promoter
regions.

Previous studies have shown the ability of BMAL1:CLOCK to recruit

enzymes to the DNA to promote the rhythmic opening of the chromatin structure,
and thus promote the rhythmic binding of adjacent transcription-factors.[226] The
demonstration that viral vectors undergo epigenetic changes and incorporate
nucleosomes in a similar fashion to genomic DNA promotes the likelihood of the
‘pioneering-factor’ hypothesis in the explanation of our results utilizing the pGL3basic luciferase reporter.[227, 228] Multiple findings in our current study support
the possibility that BMAL1:CLOCK are acting as pioneering factors to regulate the
rhythmic binding and/or activation of MYOD1 to promote the circadian oscillation
of muscle-specific genes. Most notably, the finding that over-expression of wildtype MYOD1 enhances the amplitude of the T-cap circadian rhythm. In theory, use
of a viral-vector to over-express MYOD1 should result in a non-oscillating steady
state of MYOD1 protein at all circadian time-points, and therefore the oscillation of
T-cap:luciferase activity must be due to the circadian oscillation in BMAL1:CLOCK
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activity. This is further supported by the T-cap expression iMS-Bmal1-/- muscle
tissue that displays a very low and non-oscillatory expression pattern. Additionally,
the dual-reporter assays in C2C12 muscle cells, and the fact that these transcription
factors bind at the same DNA motif, both highly suggest that MYOD1 and
BMAL1:CLOCK work as co-activators, possibly in a larger transcriptional complex.

4 Chapter 4: Future Directions
4.1 Circadian Regulation of Substrate Metabolism in Skeletal Muscle
The idea that metabolic tissues regulate the timing of anabolic and catabolic
metabolism is not novel, nor is the notion that the molecular-clock regulates many
metabolic processes throughout the body. The novelty of our study lies in our
approach to identify the acrophase (or peak expression) of metabolic genes, and our
observations that genes encoding rate-limiting metabolic enzymes are functionally
clustered in time. To our knowledge we are the first to utilize JTK_CYCLE’s ability to
accurately identify the acrophase of circadian genes in skeletal muscle, which has
allowed us to make predictions about how the molecular-clock temporally regulates
substrate metabolism. From our results we would predict that skeletal muscle is
primed for lipid-oxidation in the early active period, carbohydrate utilization in the
mid-active period, and glycogen and lipid storage toward the end of the active
phase. Since our predictions are based solely on transcript level data we require a
multitude of additional studies to determine if the circadian metabolic genes we
have identified are rhythmic at the protein-level and whether this translates into
varying rates of substrate utilization/storage throughout the day. One global
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approach would be to perform a time-course metabolomics study in wild-type mice
to assay substrate levels and metabolic rates throughout the day. Analysis of the
gene changes in the iMS-Bmal1-/- skeletal muscle has provided clues as to what
metabolic genes are downstream of the molecular clock. We predict that
BMAL1:CLOCK target genes involved in catabolic processes to be expressed during
the early active period, while we predict REV-ERB’s to target genes involved in
anabolic processes to be repressed during the active period. A time-course ChIPSeq analysis of wild-type skeletal muscle probing for both BMAL1 and REV-ERBα
would help to elucidate target genes, as well as a temporal landscape of binding.

4.2 Muscle Specific Regulation of Clock-Controlled Genes
The observation that the molecular-clock directly targets the z-line protein T-cap
suggests a novel mechanism whereby the maintenance of myofibrillar structure, and
thus muscle function, are temporally regulated. The protein expression profile of TCAP suggests that this molecule reaches peak levels during the mid- to late-active
phase. One possible explanation for the functional importance of the temporal
expression profile of T-CAP is to add or subtract stability to the myofibrils in
relation to the amount of stress the muscle will experience. In effect, having high
levels of T-CAP at the z-line could provide more stability and rigidity to the
myofibrils during the active period when the demand on skeletal muscle is high.
Since skeletal muscle is in a state of partial paralysis during sleep this period
coincides with a decreased demand for the muscle. During the inactive period low
T-CAP levels could result in a partial relaxation of the myofibrils. It is possible that
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repair mechanisms are under temporal regulation and the inactive phase may be an
optimal time to repair/reorganize the structural components within muscle. The
observations that Murf1 mRNA is highly circadian and peaks just prior to the
inactive period further supports the possibility that sarcomeric proteins are
targeted for proteasomal degradation during the inactive period. As myofibrillar
proteins turnover, the presence of a partially relaxed structure may facilitate the
incorporation of newly translated proteins and sarcomeric units. T-cap has also
been shown to interact with multiple t-tubule proteins to direct the localization of
the neuromuscular junction to the z-line. Therefore, the functional importance of
the T-CAP oscillation in muscle may also be to promote a time of day sensitivity for
excitation-contraction coupling as well as calcium induced intracellular signaling
and mechanotransduction.
We have provided evidence that the molecular-clock factors BMAL1:CLOCK work in
a synergistic fashion with the myogenic regulatory factor MYOD1 to promote the
circadian expression of the muscle-specific gene T-cap. The findings in this study
provoke numerous questions regarding the interaction of MYOD1 with
BMAL1:CLOCK. Firstly, is this interaction specific to T-cap or do MYOD1 and
BMAL1:CLOCK target the majority of muscle-specific circadian genes? Our lab is
actively pursuing these questions by performing a time-course ChIP-Seq analysis for
BMAL1 and MYOD1. These experiments will allow us to determine whether
BMAL1:CLOCK and MYOD1 target the same circadian genes, and will also allow us to
quantify the extent of binding over time of day. This may provide clues as to how
these factors are working. For instance we may be able to predict if BMAL1:CLOCK
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or MYOD1 work as pioneering factors by determining which factors bind to the
promoter regions first. We have demonstrated that the tandem-E-Box element
within the proximal promoter of T-cap appears to be the primary binding site for
BMAL1:CLOCK and MYOD1, and that it is absolutely essential for the circadian
expression of T-cap. Using the ChIP-Seq data as a guide we could perform a
bioinformatics study in which we examine the promoters of muscle-specific genes to
determine if the tandem-E-Box elements are essential for BMAL1:CLOCK and
MYOD1 cooperatively. We provided evidence that MYOD1 function is required for
the ability of BMAL1:CLOCK to drive T-cap expression (mutant MYOD1 assays).
Additional studies are required to determine if other myogenic regulatory factors,
such as MYOGENIN, can be substituted for MYOD1 and still promote the circadian
oscillation of T-cap.
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5 Chapter 5: Dissertation summary
Through the use of high-resolution time-course microarray data we were able to
identify a significantly large number of genes expressed in a circadian manner in
skeletal muscle. Utilizing the circadian statistical algorithm, JTK_CYCLE, we were
able to accurately identify the acrophase of metabolic genes, which resulted in the
observations that catabolic and anabolic metabolic processes are temporally
segregated in skeletal muscle. Our data suggests that skeletal muscle prefers lipid
oxidation in the inactive and early active-phase (morning) prior to that of
carbohydrate breakdown. In addition to rate-limiting enzymes we also identified
multiple genes that encode for activators/repressors of substrate metabolism (Pdk4,
Pdp1, Nrip1, etc). In this manner the molecular-clock controls the temporal
expression of genes that act as molecular switches, so metabolic processes are
always followed by a break to the system. These mechanisms help to promote the
precise temporal control of substrate preference or the capacity of the muscle to
store over use, or vice-versa. The observation that there is a switch toward a more
oxidative state in iMS-Bmal1-/- skeletal muscle with a decrease in genes involved in
carbohydrate metabolism strongly suggests that the molecular-clock is vitally
important in controlling the timing of carbohydrate metabolism. Since skeletal
muscle is the main site for post-prandial glucose uptake, understanding how the
molecular clock regulates carbohydrate uptake, storage, and breakdown can be a
potential new focus for understanding diseases such as diabetes, obesity, and
metabolic syndrome.
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It is becoming increasingly evident that the mechanisms in which the molecularclock regulates the precise timing is not only highly-complex, but diverse over
different cell types. Herein we provide evidence that the molecular-clock and the
myogenic regulatory factor, MYOD1, work in a synergistic fashion to promote the
expression of a muscle-specific gene. These factors not only target the same
promoter element, but seem to work as co-factors that require each other’s
presence to promote circadian rhythmicity. Future experiments are needed to
determine if the molecular-clock works with other myogenic regulatory factors, and
whether these factors changes throughout the development and maturation of
skeletal muscle. We propose that the molecular clock may be interacting with many
different tissue-specific factors to promote circadian output in a tissue dependent
manner. Identifying such factors may result in the identification of drug-able targets
for entraining the molecular-clock or promoting molecular-clock output.
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Appendix File 1. Normalized gene expression traces of circadian lipid
metabolic genes. Normalized expression traces of the circadian metabolic
genes from the high-resolution skeletal muscle time-course transcriptome
(data were downloaded from NCBI GEO datasets-GSE54652). Grey bars
indicated the active period and white bars indicate the inactive period. Note
that mice were in constant darkness during the time-course collection. Red
lines indicate the acrophase (time of peak expression) calculated by JTK_CYCLE algorithm. A 6° polynomial was fit to the data to highlight the tempo-ral
expression pattern (black line).
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Appendix File 2. Normalized gene expression traces of circadian lipid
metabolic genes. Normalized expression traces of the circadian metabolic
genes from the high-resolution skeletal muscle time-course transcriptome
(data were downloaded from NCBI GEO datasets-GSE54652). Grey bars
indicated the active period and white bars indicate the inactive period. Note
that mice were in constant darkness during the time-course collection. Red
lines indicate the acrophase (time of peak expression) calculated by JTK_CYCLE algorithm. A 6° polynomial was fit to the data to highlight the tempo-ral
expression pattern (black line).
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Appendix File 3. Normalized gene expression traces of circadian glycolytic
metabolic genes. Normalized expression traces of the circadian metabolic
genes from the high-resolution skeletal muscle time-course transcriptome
(data were downloaded from NCBI GEO datasets-GSE54652). Grey bars
indicated the active period and white bars indicate the inactive period. Note
that mice were in constant darkness during the time-course collection. Red
lines indicate the acrophase (time of peak expression) calculated by
JTK_CYCLE algorithm. A 6° polynomial was fit to the data to highlight the
temporal expression pattern (black line).
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Appendix File 4. Normalized gene expression traces of circadian glycolytic
metabolic genes. Normalized expression traces of the circadian metabolic
genes from the high-resolution skeletal muscle time-course transcriptome
(data were downloaded from NCBI GEO datasets-GSE54652). Grey bars
indicated the active period and white bars indicate the inactive period. Note
that mice were in constant darkness during the time-course collection. Red
lines indicate the acrophase (time of peak expression) calculated by
JTK_CYCLE algorithm. A 6° polynomial was �it to the data to highlight the
temporal expression pattern (black line).
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Appendix File 5. Temporal gene expression traces of circadian metabolic
genes. Gene expression traces for circadian metabolic genes from the Mouse
ST 1.0 Affymetrix gene array for gastrocnemius tissue collected at circadian
times 18 to 38. iMS-Bmal1+/+ control values are indicated as black
diamonds and iMS-Bmal1−/− are indicated as red squares. Grey bars
indicat-ed the active period, and white bars indicate the inactive period.
Note that mice were in constant darkness during the time-course collection.
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Appendix File 6. Real-time PCR results for circadian metabolic
Real-time PCR results for circadian metabolic genes. Real-time PCR
genes. Real-time
PCR resultsexpression
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expression
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for Hk2,
results
(C) of time-course
values
for Fabp3,
Pnpla3,
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0.02),Hk2 (P value =
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Appendix File 7. Temporal gene expression traces of the core moleclar-clock
genes. Gene expression traces are from the Mouse ST 1.0 Affymetrix gene
array for gastrocnemius tissue collected at circadian times 18 to 38.
iMS-Bmal1+/+ control values are indicated as black diamonds and iMS-Bmal1
−/− are indicated as red squares. Grey bars indicated the active period, and
white bars indicate the inactive period. Note that mice were in constant
darkness during the time-course collection.
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Appendix File 8. Temporal expression pattern of T-cap and Murf1 from
the Hogenesch skeletal muscle circadian transcriptome. The circles
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time-point. The dotted line is a 6-degree polynomial �itted to the expression data. Grey bars indicated the active period, and white bars indicate
the inactive period. Note that mice were in constant darkness during the
time-course collection.
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Appendix File 10. T-cap proximal promoter sequence. The letters inside the

parenthesis indicate the nucleotides following site directed mutagenesis. The

tandem E-box element is highlighted red, proximal E-box element is highlighted
green:
5’-

GAGGGCATCAGTTCCTGCTTCTCCTGTTCTGTTTACAGACAAGCTGCTGTCCTCCCTGAGC

AAGGGGGGAGCAGAGGAAGACAGTGCCAAGGTGGC(G)A(T)C(G)G(C)AGGCTGCCCATG

TGCCTGGTCCGAGGTGGTGTTTGCAGCATGCCAGACACCCAGAGGTGCTACTCTGAGAAC
CCAGGTCCCCAACAGAGCATCTTGCAGGCTTTGAAAGCTGACCTCTGACCTGGGAGCAAC

CAGAATCTGGGTACCCCAACCCCCGCCCCGGACTCAGAGCCCCATCACCACCAGTGAGTCT
TGGCTCTGCTTATAGCATCTGACGCCAGAGGGGCTGAAAATAGCCCCTGGAGAAGGGGG

AGAGGGGGAAGAAGGGGCTATTTAAAGGGCTCTGGAGGAGCAGGACATAGCAGAGGGAG

CAATCAGAAATCAGATCTGCGATCTAAGTAAGCTTGGCATTCCGGTACTGTTGGTAAAGC
CACCATGGAAGACGCCAAAAACATAAAGAAAGGCCCGGCGCCATTCTATCCGCTGGAAGA

TGGAACCGCTGGAGAGCAACTGCATAAGGCTATGAAGAGATACGCCCTGGTTCCTGGAAC

AATTGCTTTTACAGATGCACATATCGAGGTGGACATCACTTACGCTGAGTACTTCGAAAT
GTCCGTTCGGTTGGCAGAAGCTATGAAACGATATGGGCT
GAATACAAATCA-3’
!
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4. Hodge, B., Esser, K. “Titin-cap is a Clock-Controlled Gene in Skeletal
Muscle” ACSM Conference on IPE Miami Beach, Florida, September 17-20,
2014.
5. Hodge, B., Esser, K. “The molecular clock and MYOD1 work in a
synergistic fashion to promote the circadian expression of Titin-cap in
skeletal muscle” Gordon Research Conference, Excitation Contraction
Coupling Newry, Maine June 1-5, 2015.
PRESENTATIONS:
1. Hodge, B. & Utzinger, U. “Advances in Intravital Microscopy.” RICE
Symposium. Centre College, Danville, KY Spring 2010.
2. Hodge, B. & Dew, S. “Neuropharmacology of Hallucinogens.” RICE
Symposium. Centre College, Danville, KY Spring 2011.
3. Hodge, B. & Paumi, C. “Regulation of ABC Transporter Function via
Disulfide Isomerase: Eug1” RICE Symposium. Centre College, Danville, KY
Spring 2011.
4. Hodge, B. & Esser, K. “Circadian Rhythms in muscle: New Insights into
Muscle-Bone Crosstalk.” Circadian Forum. University of Kentucky,
Lexington, KY Fall 2013.
5. Hodge, B. & Esser, K. “Circadian Muscle Transcriptome Analysis.” Muscle
Forum. University of Kentucky, Lexington, KY Fall 2013.
6. Hodge, B. & Esser, K. “Circadian Muscle Transcriptome: A Bioinformatic
Approach to Understanding the Molecular Clock in Skeletal Muscle.”
Circadian Forum. University of Kentucky, Lexington, KY Spring 2014.
7. Hodge, B. & Esser, K. “Titin-cap as a Circadian Gene in Skeletal-Muscle”
Muscle Forum. University of Kentucky, Lexington, KY Fall 2014.
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INVITED PRESENTATIONS:
1. Hodge, B. “Keeping time in skeletal muscle” Biochemistry and Molecular
Biology Research Seminar, Centre College, Danville, Kentucky, April 13th,
2015.
RESEARCH INTERESTS:
•
•
•
•

•

Exercise induced mechanotransduction and downstream signaling events in
muscle.
Regulation
of
signaling
mechanisms
underlying
muscle
hypertrophy/atrophy.
Molecular mechanisms of genetic skeletal muscle diseases.
Circadian Rhythms: Tissue-specific regulation of clock-controlled genes and
how disruptions in peripheral tissue clocks affect systemic biological
processes.
Bioinformatics approaches to understanding circadian genomics.

ACTIVITIES:
•
•
•
•

Member of Varsity Football Team, 2007-2010.
Big Brothers Big Sisters of the Bluegrass, Volunteer Fall 2010-2011.
Stage Manager for a one-act play, Fall 2010.
Norton Center for the Arts, Security Fall 2010.
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